Introduction {#s1}
============

Development of the cardiovascular system takes place during the early stages of embryogenesis. Cardiac progenitors residing in the cardiac crescent are formed from the first heart field (FHF) located in the anterior lateral plate mesoderm (LPM). As the embryo develops, FHF progenitors fuse at the midline to form the primitive heart tube, which begins to beat and, as a consequence, blood begins to circulate ([@bib12]; [@bib69]). Second heart field (SHF) progenitors residing within the pharyngeal mesoderm ([@bib13]) contribute to subsequent growth and elongation of the heart tube ([@bib26]; [@bib42]; [@bib82]). In both chick and mouse embryos, the FHF gives rise to myocytes of the left ventricle and parts of the atria, whereas the SHF contributes to myocardium of the outflow tract, right ventricle, and atria ([@bib4]). Recent studies suggest that these heart fields contain both unipotent and multipotent mesodermal progenitors that give rise to the diverse lineage types within the heart ([@bib24]; [@bib31]; [@bib39]; [@bib43]; [@bib84]). For example, bipotent SHF progenitors generate endocardium or smooth muscle cells as well as cardiomyocytes ([@bib31]; [@bib43]). Cardiovascular progenitors sequentially express the cardiac transcription factors *Mesp1/2, Islet1* (*Isl1*) and *Nkx2.5,* and, in response to cues from the microenvironment, undergo lineage diversification and differentiation ([@bib30]; [@bib56]; [@bib60]).

The formation of blood vessels begins with the appearance of blood islands in the extraembryonic region. In the chick embryo, this occurs in the *area vasculosa* around St. 3--5. Sabin first proposed that some blood cells differentiate directly from endothelial cells ([@bib59]). Indeed, endothelial and blood cells that form the rudimentary circulatory system have long been thought to originate from bipotent mesoderm progenitors termed 'hemangioblasts' ([@bib10]). Recent experimental advances revealed the existence of a specialized cell, hemogenic endothelium, that harbours the potential to generate hematopoietic progenitors ([@bib3]; [@bib23]). These cells arise early in embryonic development and migrate from extra- to intra-embryonic locations ([@bib75]). However, while blood cell formation from hemogenic endothelium has been visualised directly in multiple animal models ([@bib2]; [@bib3]; [@bib27]; [@bib28]), and *in vitro* during ES cells differentiation ([@bib14]; [@bib29]), the existence in vivo of a bipotential hemangioblast that contributes to both blood and endothelial cells remains controversial ([@bib21]). Recent lineage tracing and live imaging studies addressing the ontogenic origins of hemoangiogenic cells in mouse embryos suggest that all hemogenic cells derive from a Flk1^+^/Runx1^+^/Gata1^- ^'hemogenic angioblast' population located in extraembryonic mesoderm bordering the region forming blood islands ([@bib75]). As for angioblasts that contribute to the embryonic vasculature, these cells actively migrate to embryonic sites of hemopoiesis before the establishment of circulation. Runx1 activation in the aorta-gonad-mesonephros (AGM) region is essential at this early stage for the specification of hemogenic endothelial cell fate and for definitive hemopoiesis ([@bib74]).

The origins of the myocardium have been studied intensively, although that of the endocardium remains largely obscure ([@bib20]). Early lineage tracing studies in chick have shown that myocardial and endocardial progenitors segregate at primitive streak stages ([@bib83]). In line with this view, we previously demonstrated that the endocardium originates, in part, from committed vascular endothelial progenitors that segregate medially from myocardial progenitors within the cardiac crescent ([@bib41]). Numerous studies have demonstrated the close ontological relationship between the blood and vascular lineages, and the myocardium and endocardium of the forming heart. Heart progenitor cells in the embryo, or those derived from differentiating embryonic stem cells, co-express markers of blood (*Tal1*, *Gata1*) and endothelial (*Flk1*) lineages; conversely, vascular progenitors in the yolk sac express at some point in their lineage histories multiple cardiac transcription factors including Nkx2.5, Isl1 and Tbx20 ([@bib25]; [@bib70]; [@bib71]). Studies in both fish and mouse show that the blood and heart-forming territories develop in close proximity, and are mutually antagonistic ([@bib5]; [@bib62]; [@bib80]). These territories appear to represent distinct spatio-temporal domains of the nascent mesoderm regulated in common by the transcription factor Mesp1 ([@bib7]).

*Nkx2.5* has long been known as a key transcription factor for cardiac development, specifically in the specification and differentiation of the myocardial lineage ([@bib16]; [@bib36]; [@bib78]). However, the mis-patterning of the heart and arrest of cardiac development in *Nkx2-5* null mutant mouse embryos has precluded a deep analysis of the role of this transcription factor in other mesodermal lineages. Cre recombinase-based lineage tracing with *Nkx2-*5*^irescre^* driver mice revealed a contribution of labelled cells to endothelial and blood cells in the yolk sac blood islands ([@bib70]), consistent with severe defects reported in remodelling of the yolk sac vasculature in *Nkx2-5* null embryos ([@bib73]). However, it was not determined whether this was a primary affect of loss of Nkx2-5 in yolk sac, or secondary to hemodynamic effects arising from arrested heart development.

Recent studies have begun to shed new light on the role of *Nkx2-5* in hemoangiogenic lineage specification. Nkx2-5 was found to directly bind a cis-regulatory element of the *Etv2* gene, encoding an ETS domain family transcription factor essential for formation of the embryonic and extra-embryonic endothelium, endocardium and blood lineages, and Nkx2-5 induces its expression in vitro ([@bib17]). In zebrafish, clusters of *nkx2.5*^+^ cells segregate from the main *nkx2.5*^+^ myogenic fields prior to heart formation, giving rise to the pharyngeal arch arteries ([@bib51]). Here, *nkx2.5* is essential for endothelial cell fate specification and expression of *etsrp/etv2* and *scl/tal1*. Consistent with these results, genetic lineage tracing in the mouse using the *Nkx2-5^irescre^* driver showed a contribution of Nkx2-5^+^ cells to the pharyngeal arch arteries and aortic sac, and analysis of *Nkx2-5* null embryos demonstrated that Nkx2-5 is required for pharyngeal arch artery formation ([@bib51]). Nkx2-5 and Isl1 are expressed in and required for a distinct subset of endocardial cells defined as the hemogenic endocardium, proposed to contribute to primitive and transient definitive hematopoiesis in the embryo ([@bib45]). Finally, expression of the human *NKX2-5* gene occurs in a subset of paediatric T and B cell acute lymphoblastic leukaemias defined by a t(5;14) translocation ([@bib44]; [@bib72]).

Despite this knowledge, the origins of hemogenic endothelium and endocardium, and the role of Nkx2.5 in their lineage networks in vertebrates, are poorly understood. In this study, we used chick and mouse embryonic models to investigate the origins and plasticity of early cardiovascular progenitors. Using defined early *Nkx2-5* and *Isl1* embryonic enhancers driving expression of GFP and RFP as surrogate lineage tracing tools in the chick, we revealed the origin of the cardiac hemogenic endocardium to be hemogenic angioblasts in the extraembryonic/lateral plate mesoderm. These mesodermal cells express *Nkx2.5* already in the primitive streak before migrating to the posterior LPM and extraembryonic regions, and, subsequently, into the endocardium and DA, where they form hemogenic endothelial clusters. We further demonstrated in chick, through gain-of-function experiments, that Nkx2.5 induces the expression of hemoangiogenic markers in nascent mesoderm. In mouse, *Nkx2-5^irescre^* lineage tracing demonstrated activation of *Nkx2-5* in extraembryonic tissue proximal to the cardiac crescent, and Nkx2-5^+^ cells make a substantial contribution to Runx1^+^ and CD41^+^ hemogenic endothelium in the DA and to a lesser extent endocardium. Our data provide the first in vivo evidence that Nkx2.5 has a role in initiating the hemoangiogenic program and that Nkx2.5^+^ progenitors contribute via the LPM/extraembryonic region to hemogenic endothelium of the endocardium and AGM region, and subsequently blood. Furthermore, we identify a novel population of endocardial progenitors outside the classical FHF and SHF domains.

Results {#s2}
=======

Nkx2.5 and Isl1 enhancers serve as lineage reporters highlighting spatiotemporal cardiovascular cell dynamics in live embryos {#s2-1}
-----------------------------------------------------------------------------------------------------------------------------

The chick embryo is highly suitable for the study of early development due to its accessibility for in vivo manipulations such as tissue grafting and cell fate mapping. In order to investigate the spatiotemporal dynamics of early cardiogenesis, we combined bioinformatic enhancer identification with DNA electroporation and time-lapse imaging of enhancer reporters in live chick embryos cultured *ex ovo* ([@bib79]). We first analyzed the expression in chick embryos of a previously characterized 513 bp early mouse *Nkx2-5* cardiac enhancer ([@bib34]) (*Nkx2-*5-en; [Figure 1A--E](#fig1){ref-type="fig"}; n = 30). Despite apparent lack of sequence conservation with the chick *Nkx2.5* locus, *Nkx2-5*-en was able to drive robust reporter gene expression in cardiac progenitors in live chick embryos ([Figure 1B--C](#fig1){ref-type="fig"}). *Nkx2-5*-en expression corresponded well with the mesoderm expression domain of endogenous chick *Nkx2.5* at embryonic St. 8 ([Figure 1E--E"'](#fig1){ref-type="fig"}). We then identified a conserved 830 bp regulatory element flanking the mouse genomic locus of the *Isl1* gene, which acts as an early cardiac enhancer in chick embryos (*Isl1-*en; [Figure 1F--J'](#fig1){ref-type="fig"}; n = 30, [Video 1](#media1){ref-type="other"}; n = 3). The expression of *Isl1-*en recapitulated the endogenous mesoderm and endoderm (RNA and protein) expression domains of chick Isl1 ([Figure 1I--J](#fig1){ref-type="fig"}), but was absent from ectoderm ([Figure 1J'](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).10.7554/eLife.20994.003Figure 1.Identification of novel *Nkx2-5* and *Isl1* cardiac enhancers.(**A**) Location of the *Nkx2-5* enhancer in the mouse genome. (**B--C**) Expression patterns of the enhancer-driven GFP/RFP formed in the cardiac crescent at St. 8, compared to corresponding control vectors. (**D**) *In situ* hybridization of endogenous *Nkx2.5* compared to (**E**) the mouse *Nkx2-5* enhancer. (**E\'--E'''**) Cross-section of the electroporated embryo after immunostaining for Nkx2.5 (magenta), GFP (green), and DAPI (blue). Separated channels for the *Nkx2-5*-en (**E"**) and Nkx2.5 protein (**E'''**). (**F**). Location of the *Isl1* enhancer in chick and mouse genomes. (**G--H**) Expression patterns of the enhancer-driven GFP formed in the cardiac crescent at St. eight for both chick and mouse elements. The control RFP vector is expressed in all cells. (**I**) *In situ* hybridization of endogenous *Isl1*, compared to (**J**) stage-matched mouse enhancer-electroporated embryo. (**J\'--J'''**) Cross-section of the electroporated embryo after immunostaining for Isl1 (magenta), GFP (green), and DAPI (blue). Separated channels for the mouse *Isl1*-en (**J"**) and the Isl1 protein (**J'''**). **B-E**, n = 30; **F-J**, n = 30. FHF: first heart field; SHF: second heart field; CPM: cranial paraxial mesoderm; NT: neural tube; CC: cardiac crescent. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Video 1](#media1){ref-type="other"}.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.003](10.7554/eLife.20994.003)10.7554/eLife.20994.004Figure 1---figure supplement 1.Characterization of the novel cardiac *Isl1* enhancer.(**A--D**) Expression pattern of the *Isl1*-en at different developmental stages. (**E**) The GFP pattern formed in the cardiac crescent at St. eight overlapped with the *Isl1* mRNA expression pattern and its protein expression by staining for Isl1 (red) GFP (green) and Dapi (blue). (**F--J**) Cross sections through different stages of embryonic development corresponding to the embryos shown in A-D. The mouse *Isl1-*en (green, GFP) and control pCAAG-RFP (red).**DOI:** [http://dx.doi.org/10.7554/eLife.20994.004](10.7554/eLife.20994.004)Video 1.Time lapse movie of a developing embryo expressing the *Isl1* enhancer.Relates to [Figure 1](#fig1){ref-type="fig"}. An embryo electroporated with the *Isl1*-en (GFP) plasmid at St. 3. The time-lapse video follows from St.5to St.11 when the heart tube has already formed and the embryo has begun to turn. oft: outflow; inf: inflow.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.005](10.7554/eLife.20994.005)10.7554/eLife.20994.005

Cardiac development relies on distinct cardiovascular populations {#s2-2}
-----------------------------------------------------------------

To study the dynamics of cardiac progenitor specification and migration in vivo, we co-electroporated *Isl1* and *Nkx2-5* enhancers into primitive streak-stage chick embryos ([Figure 2A](#fig2){ref-type="fig"}). Embryos were incubated overnight and monitored from St. 7 onwards. Live-cell imaging revealed the presence of both common and distinct cell populations within the cardiac crescent and adjacent developing *area vasculosa* ([Figure 2B](#fig2){ref-type="fig"}; n = 30, [Video 2](#media2){ref-type="other"}; n = 3). At St. 7--8, *Nkx2-*5-en-GFP and *Isl1-*en-RFP double-positive cells (yellow) migrated to the anterior and lateral regions of the embryo and contributed to the cardiac crescent ([Figure 2B,C](#fig2){ref-type="fig"}). However, a small proportion of electroporated cells expressed either GFP or RFP alone ([Figure 2B--E](#fig2){ref-type="fig"}). The anterior part of the heart tube (outflow region) preferentially contained GFP^+^ (Nkx2.5^+^) cardiac progenitors, while the posterior part (inflow) was mostly RFP^+^ (Isl1^+^) ([Figure 2B--E](#fig2){ref-type="fig"}). This is consistent with studies showing that the myocardium of the inflow pole of the mouse heart can form from Isl1^+^ progenitors in the absence of Nkx2.5 expression ([@bib11]).10.7554/eLife.20994.006Figure 2.*Nkx2-5* and *Isl1* enhancers mark distinct cardiac progenitor populations.(**A**) Experimental design of the *ex ovo* electroporation technique. An electric field is used to introduce different plasmids into the embryo at gastrulation (St. 3), followed by EC culture and imaging. (**B--E**) Images taken from a 24 hr time-lapse video of an embryo co-electroporated with the *Nkx2-5* (GFP) and *Isl1* (RFP) enhancers from St. 7 to St. 11. Higher magnification panels (**B'''--E'''**) of the dotted square boxes highlight the differential *Nkx2-5/Isl1* enhancers expression. Green arrow: *Nkx2-5*-en*^+^* cells; Red arrow: *Isl1*-en*^+^* cells; Yellow arrow: *Nkx2-5*-en*^+^/Isl1*-en*^+^* cells. CC: cardiac crescent; LPM: lateral plate mesoderm; HT: heart tube; smt: somites. Scale bar: 100 µm. See also [Video 2](#media2){ref-type="other"}.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.006](10.7554/eLife.20994.006)10.7554/eLife.20994.007Figure 2---figure supplement 1.Migration of *Nkx2-5*-en^+^ cells from outside the cardiac crescent towards the heart tube.(**A--H**) Time lapse analysis of a live chick embryo expressing GFP under the control of *Nkx2-5-*en analyzed at different time points. A single cell (white arrow and circle) migrating from the border of the extraembryonic/LPM and the cardiac heart field into the developing heart. Higher magnification images of the red boxes are included in the upper left corner of each panel and bring to view the traced cell. The GFP (*Nkx2-5*-en^+^ cells) and BF channels are separated.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.007](10.7554/eLife.20994.007)Video 2.Time lapse movie of a developing embryo co-expressing the *Nkx2-5* and *Isl1* enhancers.Relates to [Figure 2](#fig2){ref-type="fig"}. A St. 3 embryo was co-electroporated with the *Isl1*-en (RFP) and *Nkx2-5*-en (GFP) plasmids. The embryo was cultured overnight and time-lapse analysis started at St.6. The embryo was allowed to grow to St.11--12 when the heart tube is visible and begins to loop. The BF channel was omitted from the movie to enhance the visibility of distinct cardio-vascular progenitor populations. cc: cardiac crescent; lpm: lateral plate mesoderm; ee: extraembryonic; da: dorsal aorta; shf: second heart field.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.008](10.7554/eLife.20994.008)10.7554/eLife.20994.008

By St. 9--10, FHF/cardiac crescent cells have already fused into the primitive heart tube, which continues to grow with the addition of SHF cells at its inflow and outflow poles ([Figure 2C--E](#fig2){ref-type="fig"}). In the chick and mouse, Nkx2.5 is expressed throughout cardiac development, while Isl1 expression is transient and progressively downregulated as heart progenitors differentiate into specialised cardiomyocytes ([@bib46]). Consistently, the middle part of the primary heart tube exhibited stronger GFP expression ([Figure 2E](#fig2){ref-type="fig"}). Surprisingly, we could detect a trail of GFP^+^/RFP^-^ (*Nkx2-5*-en^+^*Isl1*-en^-^) cells extending from the LPM and extraembryonic regions towards the heart ([Figure 2D](#fig2){ref-type="fig"}, green arrowheads). This expression was not observed for *Isl1*-en-RFP, which was restricted to the primitive heart tube including both outflow and inflow tracts. Further time-lapse live imaging suggested that *Nkx2-5*-en^+^ (*Isl1*-en^-^) progenitors migrate into the forming heart via the inflow tract ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Video 2](#media2){ref-type="other"}). Taken together, our findings reveal the existence of cardiac progenitors within and outside the cardiac crescent that differ in their *Isl1* and *Nkx2.5* spatiotemporal expression patterns.

The Nkx2-5 enhancer marks hemogenic angioblast progenitors {#s2-3}
----------------------------------------------------------

Our dynamic enhancer imaging suggests that *Nkx2-5*-en-GFP marks a broad mesoderm population with both cardiac and angioblastic characteristics. The GFP^+^ angioblast progenitors form a continuum between the cardiac crescent defined by *Isl1*-en-RFP, and LPM and extraembryonic mesoderm, and are incorporated into the forming heart tube. To explore this idea further, we used a hemangioblast enhancer (Hb-en) located in the cis-regulatory region of the chick *Cerberus* gene, which marks blood islands and migratory angioblasts in the yolk sac ([@bib76]). Co-electroporation of *Nkx2-5*-en-RFP and Hb-en-GFP enhancers at St. 3 with analysis at St. 7 revealed *Nkx2-5-en*-RFP^+^ progenitors within the cardiac crescent in a pattern similar to that of *Nkx2.5* mRNA, as well as in LPM and extraembryonic mesoderm ([Figure 3A--B](#fig3){ref-type="fig"}). Hb-en-GFP was expressed only in posterior LPM/extraembryonic mesoderm bordering the *area vasculosa* of the yolk sac ([Figure 3A--C](#fig3){ref-type="fig"}; n = 17/20). Many cells co-expressed *Nkx2-5*-en-RFP and Hb-en-GFP within the LPM ([Figure 3A'''](#fig3){ref-type="fig"}, yellow arrowheads). The *Nkx2-5*-en expression domain in the LPM/extraembryonic region overlapped with that of the endothelial/blood marker *Tal1* ([Figure 3C](#fig3){ref-type="fig"}).10.7554/eLife.20994.009Figure 3.The *Nkx2-5* enhancer is expressed in a hemangiogenic cell population.(**A--A\'\'\'**) A St. 7 embryo co-electroporated with the *Nkx2-5*-en (RFP) and Hb-en (GFP). The dashed line marks the boundaries of the cardiac crescent. Red arrows represent *Nkx2-5*-en^+^ cells in the cardiac crescent; yellow arrows represent *Nkx2-5*-en^+^/Hb-en^+^ cells; green arrows represent Hb-en^+^ cells (**B**) *In situ* hybridization for the endogenous *Nkx2.5* mRNA of a St. 7 embryo. (**C**) *In situ* hybridization for the endogenous *Tal1* mRNA of a St. 7 embryo. *Tal1* expression pattern is compared to a representative *Nkx2-5*-en expression pattern from different embryo. CC: cardiac crescent; AP: area pellucida; LPM: lateral plate mesoderm; YS: yolk sac. Scale bar: 100 µm. n = 17/20. See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.009](10.7554/eLife.20994.009)10.7554/eLife.20994.010Figure 3---figure supplement 1.The Hb enhancer is active in endothelial and blood progenitors.(**A**) *In situ* hybridization of *Tal1* mRNA at St.8 (**B--B\"**) The Hb-en is expressed in the extra-embryonic region with a similar pattern to *Tal1* endogenous mRNA. Expression can also be detected in the cardiac crescent where endothelial cells give rise to the endocardium. (**C**) Example of a posterior LPM explant expressing the Hb-en, cryo-sectioned and (**D--E\"\'**) immune-stained for early hematopoietic and endothelial markers. (**F**) A posterior LPM explant expressing the *Nkx2-5*-en (red) cryo-sectioned and stained for early hematopoietic marker Runx1. (**F'--F'''**) is a higher magnification image of the square box in **F**. Co-expressing cells are marked by white arrow heads. Scale bar: 20 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.010](10.7554/eLife.20994.010)

We next explored the ability of Hb-en^+^ and *Nkx2-5*-en cells to generate vascular endothelial and hemogenic cells in vitro by culturing posterior LPM explants following the electroporation of the two reporters ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). GFP^+^ and RFP^+^ cells in LPM explants expressed endothelial (Cdh5) and hemogenic (Runx1 and CD45) mesodermal markers ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), suggesting that Hb-en^+^/*Nkx2-5*-en^+^ double positive enhancer labels hemogenic angioblasts located in the yolk sac and LPM. Based on the anatomical location , we hypothesize that *Nkx2-5*-en/Hb-en double positive cells represent hemogenic angioblasts ([@bib75]; [@bib76]) and that *Nkx2-5*-en marks distinct cardiomyocyte and hemogenic angioblast populations in the chick embryo.

Hemogenic angioblasts migrate into the heart through the inflow tract and contribute to the endocardium {#s2-4}
-------------------------------------------------------------------------------------------------------

We next assessed the contribution of Hb-en^+^ hemogenic angioblasts to the developing heart tube by electroporating Hb-en-GFP at St. 3, with analysis at St.6--11 ([Figure 4A--G](#fig4){ref-type="fig"}). Live-imaging analysis revealed GFP^+^ cells outside the cardiac crescent at St.6 that were eventually incorporated into the heart at St.11 ([Video 3](#media3){ref-type="other"}; n = 3). These cells or their daughter cells ([Figure 4A--G](#fig4){ref-type="fig"}, orange and blue arrowheads) migrated towards and incorporated into the venous pole of the heart ([Figure 4B--E](#fig4){ref-type="fig"}), while some daughters remained in the vitelline vasculature.10.7554/eLife.20994.011Figure 4.Hemangiogenic progenitors migrate to the heart through the inflow tract, and contribute to the endocardium.(**A--G**) Time-lapse images taken from an embryo electroporated with Hb-en (GFP). Images span a 24 hr time frame, from St. 6 to St. 11 of the same embryo. The orange and cyan circles distinguish between two distinct Hb-en^+^ cells. Cells were manually marked and tracked throughout the 24 hr window. (**H**) A St. 11 embryo co-electroporated with *Nkx2-5*-en and Hb-en. The embryo was sectioned at the level of the heart to show the distribution of cells within the heart tube. Arrows mark Hb-en^+^ (green), Hb^-^en^+^/*Nkx2-5*-en^+^ (yellow) and *Nkx2-5*-en^+^ (red) cells. (**H'--H'''**) include higher magnification images of single channels from the square box in **H**. (**I**) A St. 11 embryo electroporated with Hb-en. The section was immunostained for Nkx2.5 (magenta), and its expression pattern compared to that of Hb-en. (**J**) An embryo electroporated with the Hb-en-GFP and control vector pCAGG-RFP at St. 12. (**J'**) Cryo-section through the outflow tract region (OFT) of the heart shown in **J**. (**J"**) Cryo-section through the inflow tract region (IFT) of the heart shown in **J**. Yellow arrows correspond to Hb-en^+^ /pCAGG^+^ cells in the endocardium. (**K**) Quantification of Hb-en^+^ cell contribution to the myocardium compared to the contribution of pCAGG-RFP^+^ cells. (**L**) Quantification of Hb-en^+^ cell contribution to the endocardium relative to the contribution of pCAGG-RFP^+^ cells. The quantifications represent two independent experiments with n = 3. For both quantifications, double positive cells (RFP^+^/GFP^+^) were manually counted and compared to the total number of RFP^+^ cells. (**M**) Schematic representation of relative Hb-en^+^ cell contribution to different parts of the endocardium. Hb-en^+^ cells numbers are increased towards the venous (IFT) pole of the heart. CC: cardiac crescent; IFT: inflow tract; OFT: outflow tract; vent: ventricle; myo: myocardium; end: endocardium. Scale bars: 100 µm. n = 9/12. See also [Video 3](#media3){ref-type="other"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.011](10.7554/eLife.20994.011)10.7554/eLife.20994.012Figure 4---source data 1.The distribution of Hb-en^+^ cells in the chick embryo.Analysis is based on six embryos from two independent experiments. The first column represents the tissues checked for Hb-en^+^ cells. The second column represents the percentage of embryos in which Hb-en^+^ cells were detected. The third column represents the percentage of double positive Hb-en^+^/CD45^+^ cells out of the total CD45^+^ cells.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.012](10.7554/eLife.20994.012)10.7554/eLife.20994.013Figure 4---figure supplement 1.Double positive *Nkx2-5*-en^+^/Hb-en^+^ cells migrate towards the heart and yolk sac.Time-lapse images taken from an embryo electroporated with Hb-en (GFP) and *Nkx2-5*-en (RFP). Images span an 18 hr time frame, from St. six to St. 11 of the same embryo. Images were taken in a way that the cardiac crescent, LPM and extraembryonic tissues are visible simultaneously. (**A--E'**) Tracking an Hb-en^+^/*Nkx2-5*-en^+^ cell at the border between the cardiac crescent and the LPM (white arrow). (**D--J'**) Tracking an Hb-en^+^/*Nkx2-5*-en^+^ cell that is located outside of the cardiac crescent and eventually incorporated into the heart tube (cyan arrow). Note the large number of double positive cells extending from the LPM towards the extraembryonic tissue that are migrating to the yolk sac in a circulation independent matter. that cc - cardiac crescent; ee - extraembryonic tissue; lpm - lateral plate mesoderm; nt - neural tube. Scale bar: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.013](10.7554/eLife.20994.013)Video 3.Time lapse movie of a developing embryo expressing the Hb enhancer.Relates to [Figure 4](#fig4){ref-type="fig"}. A St.3 embryo electroporated with the Hb-en plasmid (GFP) and cultured overnight. The movie covers the development of the embryo between St.6 to St. 11--12. The BF and GFP channels were merged to better assess the migration of cells towards the inflow of the heart. Hb: hemangioblast; ee: extraembryonic; cc: cardiac crescent; nt: neural tube; hn; hensen's node; ap: area pellucida; da: dorsal aorta; oft: outflow; inf: inflow.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.014](10.7554/eLife.20994.014)10.7554/eLife.20994.014

We next co-electroporated embryos with both *Nkx2-5*-en and Hb-en plasmids and followed the fate of double-labelled cells. Migration of Hb-en^+^/*Nkx2-5*-en^+^ cells towards the heart and yolk sac could be tracked ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [Video 4](#media4){ref-type="other"}). Histological sections showed that expression of Hb-en (GFP^+^, green arrow) was restricted to the endocardium ([Figure 4H--I](#fig4){ref-type="fig"}), while *Nkx2-5*-en expression (RFP^+^, red arrow) was detected in both myocardium and endocardium ([Figure 4H](#fig4){ref-type="fig"}; n = 12). Importantly, *Nkx2-5*-en^+^/Hb-en^+^ (yellow) cells were found only in the endocardium ([Figure 4H](#fig4){ref-type="fig"}, yellow arrows; [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}). Nkx2.5 protein was expressed only in the myocardium at this stage ([Figure 4I](#fig4){ref-type="fig"}), indicating that *Nkx2-5*-en marks cells expressing Nkx2.5 protein at an earlier progenitor stage.Video 4.Time lapse movie of a developing embryo co-expressing the Hb and *Nkx2-5* enhancers.Relates to [Figure 4](#fig4){ref-type="fig"}. A St.3 embryo electroporated with both the Hb-en (GFP) and *Nkx2-5*-en (RFP) plasmids subsequently cultured overnight. The movie covers the development of the embryo between St.6 to St.11. The GFP and RFP channels were merged to visualize the migration of Hb-en*^+^*/*Nkx2-5*-en^+^ cells towards the inflow and the yolk sac.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.015](10.7554/eLife.20994.015)10.7554/eLife.20994.015

To quantify the contribution of hemogenic angioblasts to the endocardium, Hb-en-GFP was co-electroporated with a control *pCAGG*-RFP vector as a reference for electroporation efficiency. At St. 12, a large number of cells across the heart were *pCAGG*-RFP^+^, while Hb-en-GFP^+^ cells could be detected in a salt and pepper pattern ([Figure 4J](#fig4){ref-type="fig"}). Embryos were subsequently cryo-sectioned at the level of the heart tube and cells positive for both GFP and RFP were quantified separately in the myocardium and endocardium ([Figure 4J'--J"](#fig4){ref-type="fig"}). As expected, the contribution of Hb-en^+^ cells to the myocardium was \<0.1% ([Figure 4K](#fig4){ref-type="fig"}). In the endocardium, \~15% of electroporated pCAGG-RFP^+^ cells expressed Hb-en-GFP ([Figure 4J--J'', L](#fig4){ref-type="fig"}). Further analysis revealed that the Hb-en^+^ contribution was graded slightly but significantly between the two poles of the heart - from 13% at the arterial pole (outflow tract) to 18% at the venous pole (inflow tract) where the heart connects with the vitelline veins ([Figure 4M](#fig4){ref-type="fig"}). Taken together, our results reveal a novel population of cardiovascular progenitors located in the LPM/extraembryonic region outside the cardiac crescent, which contributes specifically to the endocardium. This progenitor population is distinct from previously characterized SHF endocardial progenitors located medial to myocardial progenitors in the cardiac crescent ([@bib41]).

Hb-en^+^ and Nkx2-5-en^+^ cells contribute to the hemogenic endothelium of the dorsal aorta {#s2-5}
-------------------------------------------------------------------------------------------

Formation of the DA involves the integration of early endothelial cells from the LPM ([@bib61]). We next determined whether Hb-en^+^/*Nkx2-5-en*^+^ cells contribute to the endothelial layer of the DA. To visualize endothelium as well as hemogenic endothelium in the DA, we used our enhancers in conjunction with a set of markers including VE-cadherin (Cdh5), CD45 and Runx1 ([Figure 5](#fig5){ref-type="fig"}). While Cdh5 labelled the entire DA endothelium, CD45 expression was restricted to hemogenic clusters in the floor of the DA at St. 17 ([Figure 5A](#fig5){ref-type="fig"}). To investigate the contribution of Hb-en^+^ cells to the hemogenic endothelium, embryos were electroporated with Hb-en and cultured for 3 days until St. 14--15. Hb-en expression was detected in the endothelial layer of the floor of the DA (n = 4/6), as well as in the endocardium (n = 6/6) but not in the cardinal vein ([Figure 5B](#fig5){ref-type="fig"}, [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}). Co-expression of the Hb-en-GFP with CD45 and Runx1 revealed hemogenic clusters in the DA, highlighting the hemogenic angioblast origin of the hemogenic endothelium ([Figure 5B](#fig5){ref-type="fig"}), in accordance with previous findings ([@bib29]; [@bib75]). We propose that hemogenic cells are incorporated into the floor of the DA during its formation from LPM.10.7554/eLife.20994.016Figure 5.Hb-en^+^ and *Nkx2-5*-en^+^ cells contribute to the hemogenic endothelium of the dorsal aorta.(**A--A"**) A St.17 embryo sectioned at the level of the AGM and stained with novel anti Cdh5 (VE-cadherin) and CD45 antibodies delineating the endothelium and hematopoietic cells, respectively. (**B--B\'\'\'**) St.14--15 embryo electroporated with the Hb-en (GFP) and sectioned at the level of the early fused dorsal aorta stained for CD45, Runx1 and GFP. The arrow marks the initiation of hemogenic clusters indicated by CD45 expression. (**C**) Section of a St.14 embryo expressing the *Nkx2-5*-en in the right aspect of the newly fused dorsal aorta (arrowheads). While no CD45 expression is detected the *Nkx2-5*-en expression co-localized with Cdh5. (**D--D\"**) Section of an early St.14 embryo expressing the *Nkx2-5*-en. Hemogenic endothelium cells are marked by Runx1 which precedes the expression of CD45. DA--dorsal aorta. Scale bars: 100 μm (**A**), 20 μm (**B--D**). Scale bar: 100 µm. n = 4/6. See also [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.016](10.7554/eLife.20994.016)

We also found *Nkx2-5*-en^+^ cells in the endothelial layer of the DA that co-expressed Cdh5 ([Figure 5C](#fig5){ref-type="fig"}, white arrows; n = 5/7). Earlier, at St.13--14, these cells were localized at the lateral edge of the newly fused DA and failed to express CD45, although, Runx1, an early hematopoietic stem cell marker known to be activated in hemogenic cells of the DA ([@bib49]), was co-expressed with *Nkx2-5*-en^+^ cells at this stage ([Figure 5D](#fig5){ref-type="fig"}). These results suggest that *Nkx2.5*^+^ hemogenic angioblasts contribute to the endothelial layer and hemogenic endothelium of the DA during its formation.

Hb-en^+^ and Nkx2-5-en^+^ cells give rise to hemogenic endocardium {#s2-6}
------------------------------------------------------------------

We next sought to investigate the contribution of Hb-en^+^ and *Nkx2-5*-en^+^ cells to hemogenic endocardium, recently reported to derive from the *Nkx2-5*^+^ lineage in the mouse ([@bib45]). Currently, the origin of these cells is unknown. Endocardial cells co expressing *Nkx2-5*-en^+^ and Cdh5^+^ could be detected in St.13--14 chick embryos ([Figure 6A](#fig6){ref-type="fig"}) and we found that a subset of these cells had the same marker profile as in the DA ([Figure 6B](#fig6){ref-type="fig"}). At the level of the developing ventricle, we observed Hb-en-GFP^+^ cells co-expressing either CD45 or Runx1, or both ([Figure 6C--D](#fig6){ref-type="fig"}). Taken together, our data suggest that the hemogenic endothelium within the primitive heart tube of the chick embryo is derived from hemogenic angioblasts within the LPM/extraembryonic mesoderm.10.7554/eLife.20994.017Figure 6.Hb-en^+^ and *Nkx2-5*-en^+^ cells give rise to hemogenic endocardium.(**A**) Section through a heart of a St.12--13 embryo expressing the *Nkx2-5*-en. Staining for Cdh5 delineates the endocardium (white arrow) which expresses the *Nkx2-5*-en. (**B**) High magnification of a section through the heart of a St13-14 embryo expressing *Nkx2-5*-en. A hemogenic cluster is attached to the endocardium delineated by Cdh5 and CD45 staining. (**C**) St.14--15 embryo electroporated with the Hb-en sectioned at the level of the heart. (**C\'--C\'\'\'**) Higher magnification of the square box area marked in **C**. The section was stained for CD45 and shows a large hemogenic cluster in the endocardium. The arrow indicates Hb-en^+^ cells that express CD45. The endocardium and myocardium are delineated by grey and pink dashed lines, respectively. The dashed red line delineates the hemogenic cell cluster. (**D**) St.14--15 embryo electroporated with the Hb-en and sectioned at the level of the heart tube. (**D\'--D\'\'\'**) Higher magnification of the square box area marked in **D**. The section was stained for CD45, Runx1 and GFP. White arrow highlights an Hb-en^+^ cell co-expressing CD45 and Runx1. For each dotted red line a higher magnification image is shown at the upper right side of the panel. end: endocardium; myo: myocardium. Scale bars: 100 µm, B -- 20 µm. n = 4/6.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.017](10.7554/eLife.20994.017)

Nkx2.5 is expressed in the nascent mesoderm in the primitive streak of chick embryos {#s2-7}
------------------------------------------------------------------------------------

To examine the potential of Nkx2.5 to induce cardiovascular/blood lineage commitment in chick embryos, we first compared the expression profile of key cardiovascular and blood transcription factors at St. 7 (cardiac crescent stage; [Figure 7A](#fig7){ref-type="fig"}). Regional expression of these factors can be seen along the medial-lateral and anterior-posterior axes in zones generally defined as 'cardiac' (*Tbx5, Isl1, Nkx2.5*), 'cardiovascular' (*Isl1, Nkx2.5, Gata4, Tal1*), and 'blood' (*Tal1, Runx1*) -forming territories. In chick, *Tbx5* is expressed in FHF cells as they begin to differentiate into cardiomyocytes ([@bib46]; [@bib55]; [@bib77]), while *Nkx2.5* and *Isl1* are expressed throughout the anterior LPM in both FHF and SHF progenitors and pharyngeal endoderm ([@bib46]; [@bib77]). *Gata4* is expressed more lateral and posterior to these two factors. The endothelial/blood marker *Tal1* is highly expressed in the posterior LPM and extraembryonic tissues, whereas the blood/hematopoietic lineage marker *Runx1* marks only extraembryonic blood islands, more lateral to cells expressing *Tal1*. This ISH analysis reveals the existence of both overlapping and distinct developmental fields (illustrated in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).10.7554/eLife.20994.018Figure 7.*Nkx2.5* is expressed in the nascent mesoderm in the chick primitive streak.(**A**) The cardiovascular network gradient. *In situ* hybridization of key genes involved in blood, vascular and cardiac development. (**B**) Semi qRT-PCR analysis of cardiovascular genes in early St. 3 (red box) and St. 4 (blue box) embryos. (**C--C'**) A St. 3--4 embryo electroporated with the *Nkx2-5*-en. (**C'**) shows a higher magnification of the square box in (**C**), displaying the GFP channel and the merge with the BF channel. (**D**) Wholemount immunofluorescence staining for Nkx2.5 on late St. 4 embryo. (**E**) Wholemount immunofluorescence of St. 8 embryo. Nkx2.5 expression is restricted to the cardiac crescent. (**F**) Semi qRT-PCR time course analysis of *Nkx2.5* mRNA expression at different embryonic stages and tissues. *Nkx2.5* expression is highlighted in yellow boxes. *GAPDH* is used as control. CC: cardiac crescent; NT: neural tube; PS: primitive streak. Scale Bars -- **C**: 100 µm; **C'**: 25 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.018](10.7554/eLife.20994.018)10.7554/eLife.20994.019Figure 7---figure supplement 1.Key cardiovascular gene expression gradient in a chick embryo.(**A**) Super-position of the different cardiovascular factors on a single embryo based on *in situ* hybridization and semi qRT-PCR analysis. (**B**) Semi qRT-PCR analysis of cardiovascular genes in a St.8^-^ embryo. The embryo is divided to four sections that are manually dissected and subjected to RNA analysis. Representative results of three different biological repeats. lpm -- lateral plate mesoderm; np -- neural plate; cc -- cardiac crescent; ee -- extraembryonic tissue.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.019](10.7554/eLife.20994.019)

*Nkx2.5* mRNA expression at St. 7 is restricted to the cardiac crescent, while the enhancer is also expressed in the posterior LPM ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"} and [7](#fig7){ref-type="fig"}). Enhancer activity in the LPM could be explained by the lack of negative *cis* regulatory elements within this fragment. Alternatively, it could reflect the stability and perdurance of the fluorescent reporters (GFP or RFP), which would serve as lineage tracing tools marking all cells that have expressed *Nkx2.5* in their recent history. To address this issue, we performed RT-PCR analysis to ask whether *Nkx2.5* is expressed in eartly gastrulating St.3--4 embryos, when early cardiovascular progenitors emerge ([@bib35]). At these early stages cardiac progenitors were localized at the anterior primitive streak, while blood progenitors and *Nkx2-5*-en^+^ were restricted to the mid-posterior streak ([@bib63]; [@bib64]). Analysis of mid-primitive streak tissue detected *Nkx2.5*, but not *Isl1,* RNA expression, along with the earliest markers of mesoderm, *Mesp2* (homolog of mouse *Mesp1*) ([@bib60]) and *Brachyury* (*Bry*) ([Figure 7B](#fig7){ref-type="fig"}; red and blue boxes, n = 18). Hemoangiogenic markers *Ets1*, *Flk1*, *Gata4*, *CD31*, Runx1 and *Tal1*, were also detected at these stages. Consistent with these finding, we detected expression of *Nkx2-5*-en in the mid-streak at these same stages, marking nascent mesodermal progenitors. Wholemount immunofluorescence staining of St. 4 embryos revealed multiple Nkx2.5^+^ cells in and outside the primitive streak region ([Figure 7D](#fig7){ref-type="fig"}), while at St. 8 Nkx2.5 was expressed exclusively in the cardiac crescent ([Figure 7E](#fig7){ref-type="fig"}). *Nkx2.5* mRNA was also transiently expressed in the posterior LPM at St. 5--6 ([Figure 7F](#fig7){ref-type="fig"}, yellow box) in addition to strong and sustained expression within the anterior LPM (cardiac crescent). Lower expression was observed in extraembryonic tissue at St. 6, which was downregulated when embryos reached St. 7, in-line with inhibition of the cardiac developmental program in the posterior LPM and extraembryonic tissue ([@bib62]; [@bib80]).

In-depth RT-PCR analysis at St. 7 embryos was performed for the extraembryonic mesoderm, LPM, cardiac crescent and neural plate tissues ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, n = 20). A mixture of endothelial and blood gene expression signatures (*Flk1, Tal1*, *Ets1, CD31, Gata1, Runx1*) was observed in both extraembryonic and LPM tissues, while the cardiac crescent expressed *Nkx2.5, Isl1 and Tbx5* ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Taken together, our molecular analyses suggest that in the chick transient expression of *Nkx2.5* marks hemoangiogenic progenitors in extra-cardiac regions from early primitive streak stages through St 6, just prior to formation of the cardiac crescent. These results are consistent with *Nkx2-5*-en serving as a lineage-tracing tool for *Nkx2.5*-expressing mesodermal cells in gastrula and immediate post-gastrula stages.

Ectopic expression of Nkx2.5 induces hemangioblast gene expression {#s2-8}
------------------------------------------------------------------

Our findings suggest that *Nkx2.5* marks hemoangiogenic progenitors in chick nascent mesoderm. To examine the competence of nacent mesoderm to respond to Nkx2.5 expression, we performed Nkx2.5 gain-of-function experiments by electroporating the pCIG-*Nkx2.5* construct at St. 3, with analysis at St. 7 (cardiac crescent stage, [Figure 8](#fig8){ref-type="fig"}). Strikingly, enforced expression of Nkx2.5 at St. 3 induced robust expression of hemoangiogenic genes, including *Tal1*, *Flk1*, *Ets1* and *Lmo2* (red arrows, n = 6/8; n = 8/11; n = 4/5; n = 5/7, respectively, [Figure 8A'--D'](#fig8){ref-type="fig"}). Ectopic expression of these genes was observed at sites of high Nkx2.5 expression (lower panels), indicating a cell autonomous effect. Furthermore, Nkx2.5 overexpression inhibited somite formation and *Pax3* expression, indicating strong lateralization of the paraxial mesoderm ([Figure 8E--E"](#fig8){ref-type="fig"}; n = 5/6).10.7554/eLife.20994.020Figure 8.Ectopic expression of Nkx2.5 induces angioblast gene expression.(**A--E**) *In situ* hybridization for *Tal1, Flk1, Ets1* and *Lmo2* and *Pax3* in control embryos. (**A'--E'**) Embryos electroporated at St.3 with a vector over-expressing Nkx2.5 (pCIG-*Nkx2.5*-GFP). Embryos were subsequently incubated to St.7 and then subjected to *in situ* hybridization for the respected genes. Red arrow indicates where the ectopic expression of a gene was detected compared to its control embryo. (**A"--E"**) The same embryos as in **A\'--E\'** merged with the GFP channel visualizing the Nkx2.5 over-expressing tissues. The over-expressing phenotype corresponds to the area where the vector expression was the highest. Scale bar: 100 μm. See also [Figure 9---figure supplements 1](#fig9s1){ref-type="fig"} and [2](#fig9s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.020](10.7554/eLife.20994.020)10.7554/eLife.20994.021Figure 8---figure supplement 1.Tal1 over-expression inhibits cardiogenesis.The coding sequence of chick Tal1 was cloned into an expression vector and electroporated into St.3 embryos. (**A**,**C**,**E**,**G**) Expression profile in WT control embryos. (**B**,**D**,**F**,**H**) Expression profile in Tal1 gain-of-function embryos. (**B\'**,**D\'**,**F\'**,**H\'**) GFP expression marks the cells where Tal1 is expressed. (**B\"**,**D\"**,**F\"**,**H\"**) Overlay of the GFP signal and the in-situ hybridization assay. The yellow dotted line represents the normal borders of the cardiac crescent.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.021](10.7554/eLife.20994.021)10.7554/eLife.20994.022Figure 8---figure supplement 2.Tal1 over-expression impairs normal heart development.(**A**) Control St.13 WT embryo. (**B**) Tal1 over-expressing embryo with edema. (**C**) Tal1 over-expressing embryo with defected cardiac looping and size. (**D**) Tal1 over-expressing embryo with ectopic intra-embryonic blood islands. (**E--I**) Higher magnification of the square box in D. Tal1 -- GFP; *Nkx2-5*-en -- RFP.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.022](10.7554/eLife.20994.022)

In a similar fashion, we performed overexpression experiments with Tal1 ([Figure 8---figure supplements 1](#fig8s1){ref-type="fig"} and [2](#fig8s2){ref-type="fig"}). Tal1 overexpression suppressed cardiac genes, mostly within the caudal part of the cardiac crescent ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}, n = 21/27). Furthermore, the cardiac crescent appeared smaller in Tal1 electroporated embryos. At later stages (St. 12--13), Tal1 expression resulted in cardiac looping defects and the appearance of edemas ([Figure 8---figure supplement 2A--C](#fig8s2){ref-type="fig"}, n = 14/17). Furthermore, we observed ectopic blood island formation in the posterior LPM, where *Nkx2-5-*en was also expressed ([Figure 8---figure supplement 2D--I](#fig8s2){ref-type="fig"}, n = 10/17). Collectively, our data indicate that in the chick, nascent mid-streak mesoderm transiently expresses *Nkx2.5* mRNA. Furthermore, it is competent to respond to Nkx2.5 over-expression through engagement of a hemoangiogenic program. Overexpression of Tal1, a definitive hemogenic transcription factor, overides the endogenous cardiac program and redirects it to blood. Our data suggest that *Nkx2-5-*en provides a robust readout of Nkx2.5^+^ lineage expansion and migration in the chick, and that the first role for Nkx2.5 in the embryo is as a hemoangiogenic transcription factor, before its latter involvement in cardiac regulatory networks.

Mouse Nkx2-5 lineage^+^ cells contribute to yolk sac vasculature {#s2-9}
----------------------------------------------------------------

Previous CRE/loxP genetic lineage tracing studies in mouse embryos have demonstrated a contribution of Nkx2-5 lineage^+^ cells to yolk sac blood island endothelium at E10.5 ([@bib70]) and hemogenic endocardium at E9.5 ([@bib45]). However, the origins of these cells and their contribution to the AGM region of the DA have not been explored. We crossed the *Nkx2-5^irescre^* mice to *Rosa-LacZ, Rosa-YFP* or *Z/EG* reporter lines, and examined embryos for marked tissues at E7.5-E10.5. Whole mount staining for β-gal in *Nkx2-5^irescre/+^;Rosa^lacZ/+^* embryos revealed the presence of isolated labelled cells in extra-embryonic yolk sac mesoderm at \~E70.5-E8.0, coincident with the earliest first appearance of labelling in the cardiac crescent, although not in pre-crescent embryos ([Figure 9A](#fig9){ref-type="fig"}; [Figure 9---figure supplement 1A,A'](#fig9s1){ref-type="fig"}). More labelled yolk sac cells were evident during heart tube formation ([Figure 9B](#fig9){ref-type="fig"}). Labelled cells tended to be proximal to the crescent and restricted to the anterior half of the yolk sac ([Figure 9A,B](#fig9){ref-type="fig"}). As development progressed further, the number of labelled cells increased dramatically, such that by E9.0 there were many positive cells associated with the yolk sac vasculature ([Figure 9D](#fig9){ref-type="fig"}, [Figure 9---figure supplement 1D,D'](#fig9s1){ref-type="fig"}). At this stage, isolated lineage-tagged cells were also seen within the cardio-pharyngeal region of the embryo extending into the head, as well as more caudally in the trunk and tail ([Figure 9C](#fig9){ref-type="fig"}). Histological sections of yolk sac showed that from E8.0, lineage tagged cells contributed only to the mesodermal layer including the endothelial lining of forming vessels ([Figure 9---figure supplement 1B--D''](#fig9s1){ref-type="fig"}). Moreover, at E9.0, the majority of *Nkx2-5* lineage-traced cells in the yolk sac vasculature also expressed endothelial markers Vegfr2/Flk1 and VE-cadherin/Cdh5 ([Figure 9---figure supplements 2A--E'''](#fig9s2){ref-type="fig"}), suggesting their endothelial nature. However, the yolk sac vasculature was a mosaic of lineage labelled and unlabelled cells ([Figure 9---figure supplement 1D'](#fig9s1){ref-type="fig"}). Labelled blood cells were also evident within vessels ([Figure 9---figure supplement 1D,D''](#fig9s1){ref-type="fig"}). We note that Nakano and colleagues did not see significant labelling in yolk sac at E9.5 using identical (*Nkx2-5^irescre/+^;Rosa26^lacZ/+^*) or similar (*Nkx2-5^irescre/+^;Rosa26^YFP/+^*) lineage tracing crosses ([@bib45]), which we attribute to the lower sensitivities of CRE reporters on different genetic backgrounds.10.7554/eLife.20994.023Figure 9.An *Nkx2-5^+^* lineage contributes to hemogenic endothelium of the dorsal aorta in the mouse.(**A--D**) Lineage tracing β-gal staining of *Nkx2-5^irescre^;R26R* embryos. (**A**) E7.5 showing β-gal staining beginning in the cardiac crescent (cc) and yolk sac (ys). (**B**) E8.0 showing β-gal staining in the forming heart (fh) and yolk sac. Red arrows in A and B indicate β-gal positive cells in the anterior half of yolk sac. (**C**) E9.5 showing β-gal staining in the looped heart (ht) and associated pharyngeal region extending into the head (potentially angiogenic cells or blood cells). Isolated cells are also found within the trunk and tail regions of the embryo (red arrows). (**D**) E9.5 showing β-gal staining in the yolk sac marking angiogenic and potentially hemoangiogenic cells within the vasculature (red arrows; see sections in [Figure 9---figure supplement 1B--D'](#fig9s1){ref-type="fig"}). (**E--H**) Nkx2-5 expression β-gal staining of *Nkx2-5^lacZ/+^* embryos. (**E--F**) E7.5 showing *Nkx2-5*-LacZ expression in the cardiac crescent and proximal yolk sac. Red arrows show single β-gal positive cells in yolk sac in close proximity to the cardiac crescent. (**G--H**) E8.0 (**G**) and E9.0 (**H**) embryos showing *Nkx2-5*-LacZ expression in the forming heart and looped heart respectively. Red arrows show caudal parts of the cardiac zone that contain positive cells in yolk sac. (**I--I'''**) E10.5 *Nkx2-5^irescre^;ROSA^YFP^* embryos sectioned at the level of the aorta gonad mesonephros (AGM) region and immunostained for Runx1 (red) and YFP (green). Co-labelled Runx1^+^ YFP^+^ cells are present mostly in the floor of the dorsal aorta (da). (**J--J'''**) E10.5 *Nkx2-5^irescre^;ROSA^YFP^* embryo depicting *Nkx2-5* lineage^+^ (YFP^+^) hemogenic cells (Runx1^+^) protruding from the endothelial layer of the dorsal aorta in the AGM region. (**K--L'''**) E10.5 embryos showing co-staining for *Nkx2-5*-lineage^+^ (YFP^+^) and Runx1^+^ (**K--K'''**) or CD41^+^ (**L--L'''**) cells in the developing liver. Yellow arrows in **I-K'''** mark YFP^+^ Runx1^+^ cells and in **L-L'''** mark YFP^+^ CD41^+^ co-labelled cells. Green arrows in **J** and **J''** depict YFP^+^ Runx1^-^ single positive cells. Scale bar: **A-H** - 100 µm; **I-J''** - 50 µm; **K-L''** - 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.023](10.7554/eLife.20994.023)10.7554/eLife.20994.024Figure 9---figure supplement 1.*Nkx2-5* is transiently expressed in yolk sac mesoderm from cardiac crescent stages.(**A**) Lateral view of whole mount β-gal staining in an E7.0 mid-gastrula-stage *Nkx2-5^+/+^;R26R* (control) embryo. Weak background is detected sporadically across the yolk sac (ys). (**A'**) Lateral view of an E7.0 *Nkx2-5^irescre/+^;R26R* embryo. Note lack of β-gal-positive cells in the embryo and yolk sac. (**B--D''**) Cryo-sections of *Nkx2-5^irescre/+^;R26R* embryos through the forming heart (ft) and yolk sac at E8.0, E8.5, and E9.0, respectively, showing isolated β-gal-positive cells in the yolk sac vessel mesothelium. Labelling is also seen in the foregut (fg) and pericardium (p). Vessel staining is mosaic - in some vessels most or all mesothelial cells are labelled (**C', D**) while in others few or none are labelled (**D'**). A positive blood cell within a yolk sac vessel is also shown (**D**; arrowhead). (**D''**) Additional section showing labelled blood cells within a yolk sac vessel at E9.0 (arrowhead). (**E--E'**) early and mid-primitive streak stage *Nkx2-5^lacZ/+^*embryos at \~E70.0. No β-gal-positive cells are seen in the embryo or yolk sac. (**F**) E7.5 *Nkx2-5^lacZ/+^*embryo showing the earliest detectable labelling of in the cardiac crescent (cc) and yolk sac (arrows). (**G--G'**) Cryo-section of E7.5 embryos showing clusters of labelled cells in the cardiac crescent, and isolated cells embedded within the mesodermal layer of the yolk sac (arrows). (**H**) Cryosection through the forming heart region of E8.0 embryo showing β-gal-positive cells in yolk sac mesoderm and endoderm (arrows) only in close association with the heart. Scale bars: 100 μm. (**I**) Graph showing quantification of Runx1^+^ and YFP^+^ cells in the floor of the dorsal aorta in the AGM region of E10.5 *Nkx2-5^irescre/+^;ROSA^YFP/+^* embryos (n = 3 embryos; average number of cells/section with standard deviation). (**J--J'''**) Transverse section of E10.5 *Nkx2-5^irescre/+^;ROSA^YFP/+^* embryo through the region of AGM immunostained for Runx1 (red) and *Nkx2-5^+^* lineage traced YFP^+^ cells. Nuclei indicated by Hoechst. Yellow arrows mark YFP^+^ Runx1^+^ cells; red arrows mark YFP^-^ Runx1^+^ cells; green arrows mark YFP^+^ Runx1^-^ cells in the endothelium. Note, the majority of Runx1^+^ cell are YFP^-^ both in the endothelium and sub-endothelial regions of the AGM. These stainings complement those shown in [Figure 9I--J'''](#fig9){ref-type="fig"} and indicate a section in which there are several *Nkx2-5*-lineage traced YFP^+^ cells that are Runx1^-^ (quantified in panel **I**). Scale bar: 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.024](10.7554/eLife.20994.024)10.7554/eLife.20994.025Figure 9---figure supplement 2.*Nkx2-5^+^* lineage contributes to hemogenic endothelium of yolk sac vasculature.Co-immunostaining of E9.0 *Nkx2-5^irescre^;ROSA^YFP^* (**A--C'''**) and *Nkx2-5^irescre^;Z/EG* (**D--E'''**) embryos. (**A-B'''**; **D--D'''**). Cryosections of yolk sac immunostained for YFP (green) and endothelial marker Vegfr2/Flk1 (Red). Co-localization of *Nkx2-5^+^* lineage traced YFP^+^ cells and Vegfr2 was observed in the mesothelium of vessels as marked by arrows. (**C-C'''**; **E--E'''**). Immunostaining of yolk sac cryosections for *Nkx2-5*-lineage traced YFP^+^ cells (green) and VE-cadherin (red). Arrows depict co-localization of YFP^+^ cells with VE-cadherin. Scale bar: 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.025](10.7554/eLife.20994.025)10.7554/eLife.20994.026Figure 9---figure supplement 3.*Nkx2-5* expression in single cells of mouse E7. 0--7.75 embryos.(**A**) t-SNE plots were used to visualize single cells transiting through stages of mouse mesodermal development in vivo, with cell clustering and identification of subtypes based on categorizations determined previously (left plot) ([@bib65]). *Nkx2-5* expression is shown overlaid across these populations (right plot). (**B--C**) The fraction of cells expressing *Nkx2-5* (**B**) and violin plots depicting the distribution of *Nkx2-5* expression levels (**C**) are shown for each of the nine different cell populations identified including mesodermal populations as well as epiblast and extra-embryonic ectoderm. Dashed line in **C** represents chosen threshold of 1 normalised read count/cell.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.026](10.7554/eLife.20994.026)10.7554/eLife.20994.027Figure 9---figure supplement 4.Spatial RNA-seq analysis of Nkx2-5 expression in mouse gastrula-stage embryos.(**A--C**) 'Corn plots' showing examples of the spatial domains of *Nkx2-5* expression in the epiblast, ectoderm and mesoderm of mouse embryo at different stages of gastrulation (taken from published RNA-seq data at E7.0 (n = 3) ([@bib54]) and unpublished data at E6.5 (n = 4) and E7.5 (n = 3)). (**A**) E6.5: anterior (**A**) and posterior (P) halves at seven proximo-distal levels. In the example shown, only segment A3 showed expression. (**B**) E7.0: A, P, left (L) and right (R) quadrants at 11 proximo-distal levels (A and P only from level 1) (upper panel); and mesoderm pooled from both sides (**M**) and posterior epiblast quadrant containing primitive streak (**P**) at 12 proximo-distal levels (lower panel). (**C**) E7.5: A and P quadrants, left and right anterior lateral quadrants (L1, R1) and left and right posterior lateral half quadrants (L2, R2) at nine proximo-distal levels (A and P only in level 1) (upper panel); and separate left and right mesodermal wings (M1 and M2) compared to posterior ectoderm quadrant at nine proximo-distal levels (lower panel). Scales represent levels of *Nkx2-5* expression as log10 of fragments per kilobase million (FPKM +1) (**D**) *Nkx2-5* expression level (mean log10 of FPKM ± standard deviation of replicates) in the positive segments describe in (**A--C**) above ([@bib54]). (**E**) Table of *Nkx2-5* spatial expression values (log10 of FPKM) used to construct corn plots shown in (**A--C**). Segments in which there were no detectable transcripts are not shown.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.027](10.7554/eLife.20994.027)10.7554/eLife.20994.028Figure 9---figure supplement 5.*Nkx2-5* lineage^+^ cells in the cardio-pharyngeal region.(**A--E"**) Co-immunostaining of cryo-sections from E10.5 *Nkx2-5^irescre^; ROSA^YFP^* (**A--D**) and *Nkx2-5^irescre^;Z/EG* (**E--E"**) embryos. (**A**) Section showing Nkx2-5 lineage traced cells (YFP^+^) in the endothelium of the pharyngeal arch arteries (paa) and endoderm of foregut (fg). In pharyngeal arch arteries, YFP^+^ cells do not express Runx1 (white arrows), however note co-expression of YFP and Runx1 in the foregut floor and ectoderm lateral to one pharyngeal arch artery. (**B**) *Nkx2-5* lineage traced YFP^+^ cells contribute extensively to the myocardium of outflow tract (oft), atrium (a), ventricle (v) and atrio-ventricular cushion tissue (c), as well as liver (li). Few Runx1^+^YFP^-^ cells were observed in cushion tissues (arrows) which are potentially blood cells. Other Runx1^+^YFP^-^ blood cells can be seen within the atrium and pericardium (haemorrhaged during preparation). (**C--D**) CD41^+^YFP^+^ endothelial (and potentially hemogenic) cells observed in the atrium, ventricles and paired anterior dorsal aorta (da) (yellow arrows). One double positive cell in the atrium may be in the process of extrusion into the lumen. One CD41+YFP- cell is also shown (white arrow). (**E--E"**) Co-immunostaining demonstrates *Nkx2-5* lineage traced GFP^+^ cells embedded within Pecam1^+^ endothelial cells of anterior dorsal aorta (white arrows). Scale bar: A-D; 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.028](10.7554/eLife.20994.028)

To explore further the lineage identities of those cells first expressing *Nkx2-5* in mouse embryos at E7.5, we interrogated recently published transcriptome data of single cells derived from the epiblast and mesoderm of E7.0-E7.75 embryos, whose lineage identities had been determined based on cell surface marker status (Flk1; CD41) and transcriptome signature ([@bib65]). No cells classified as epiblast or extra-embryonic ectoderm expressed *Nkx2-5* ([Figure 9---figure supplement 3A--C](#fig9s3){ref-type="fig"}). However, *Nkx2-5* was expressed in \~7% of cells classified as nascent mesoderm and \~30% of cells classified as posterior and pharyngeal mesoderm (likely cardiac progenitors). Importantly, \~30% of endothelial cells and an equivalent proportion of cells classified as allantois (one extra-embryonic site of hemopoiesis) were *Nkx2-5*^+^, as were \~10% of early blood progenitors. These data confirm the hemoangiogenic nature of Nkx2-5 lineage-traced cells in early mouse embryos.

Onset of Nkx2-5 expression in mouse embryos {#s2-10}
-------------------------------------------

It is noteworthy that Nkx2-5-Cre mediated lineage-tagged cells were not found in late gastrula/pre-crescent stage embryos at E7.0 ([Figure](#fig9s1){ref-type="fig"} [9---figure supplement 1A,A'](#fig9s1){ref-type="fig"}). Lack of significant *Nkx2-5* mRNA expression in early to mid-gastrula stage embryos was supported by interrogation of a previously published high-resolution spatial RNA-seq map of E7.0 mid-gastrula stage embryos ([@bib54]), as well as similar maps from E6.5 early gastrula and E7.5 late gastrula/pre-cardiac crescent stage embryos (unpublished data from S.S., J-D.J.H., G.P., N.J. and P.P.L.T.; summarized in [Figure 9---figure supplement 4A--E](#fig9s4){ref-type="fig"}). No consistent spatial pattern of *Nkx2-5* expression was obtained in proximo-distal and anterior-posterior embryonic segments of epiblast at early gastrulation (n = 4, [Figure 9---figure supplement 4A](#fig9s4){ref-type="fig"}). Where expression did register, it occurred in sporadic segments, and the mean and maximum normalized read counts (log~10~ of fragments per kilobase million \[FPKM\]) were very low (mean 0.18 ± 0.08, range 0.09--0.25; [Figure 9---figure supplement 4D,E](#fig9s4){ref-type="fig"}). Similarly, at mid-gastrulation (E7.0; n = 3), only very low read counts registered in epiblast (mostly in a single replicate; mean 0.07 ± 0.07, range 0.032--0.32), and nascent mesoderm (mean 0.58 ± 0.67, range 0.09--1.35) ([Figure 9---figure supplement 4B,D,E](#fig9s4){ref-type="fig"}). In contrast, in E7.5 late gastrula/pre-cardiac crescent stage embryos, significantly higher read counts registered in coherent clusters of segments in nascent mesoderm in 2 of the three replicates (mean 5.6 ± 5.9, range 0.07--20.1) while only low counts were found in ectoderm in sporadic segments (mean 0.32 ± 0.36, range 0.03--1.1) ([Figure 9---figure supplement 4D,E](#fig9s4){ref-type="fig"}). The higher number of counts in clusters of segments in E7.5 nascent mesoderm likely reflects the upward slope of the Nkx2-5 expression profile during specification of cardiomyocytes in the cardiac crescent.

The RNA-seq profiles in mouse embryos are therefore consistent with our lineage tracing data detecting the onset of *Nkx2-5* expression at the pre-crescent/crescent transition. Taking a complementary approach, we explored the timing and location of *Nkx2-5* expression using the sensitive *Nkx2-5^LacZ^* knockin allele ([@bib56])([Figure 9E--H](#fig9){ref-type="fig"}). Similar to our findings with lineage tracing and RNA-seq, the earliest expression of β-gal in extra-embryonic tissue of *Nkx2-5^LacZ/+^* embryos was at E7.5, when the cardiac crescent was established ([Figure 9E,F](#fig9){ref-type="fig"}; [Figure 9---figure supplement 1E--F](#fig9s1){ref-type="fig"}). Even when only few cells were β-gal positive in the crescent, a comparable number of positive cells were evident in the yolk sac ([Figure 9---figure supplement 1F](#fig9s1){ref-type="fig"}). Labelling was in the mesodermal layer proximal to the cardiac crescent ([Figure 9E,F](#fig9){ref-type="fig"}; [Figure 9---figure supplement 1F--G'](#fig9s1){ref-type="fig"}). However, by forming heart tube and looping heart stages, positive cells in the yolk sac were only rarely evident ([Figure 9G,H](#fig9){ref-type="fig"}), although visual inspection of whole mount stained E8.0 embryos and histological sectioning, showed positive cells in yolk sac at the caudal territories of the cardiac zone ([Figure 9G](#fig9){ref-type="fig"}, arrows) and in yolk sac mesoderm and endoderm immediately overlying the heart region ([Figure 9---figure supplement 1H,H'](#fig9s1){ref-type="fig"}). Interestingly, both lineage tracing and *Nkx2-5*-LacZ expression showed that labelled endodermal cells were not seen in the yolk sac layer distal to the cardiac zone, and those located proximally likely remain associated with the foregut. We conclude that in mouse, *Nkx2-5* is activated transiently in extra-embryonic mesoderm in close association with the cardiac crescent at E7.5-E8.0. The combination of expression analysis, lineage tracing and RNA-seq suggests that these cells expand as they move deeper into the yolk sac and populate vascular structures. We anticipate that the Nkx2-5^+^ cells present at E7.5-E8.0 are the founders of the Nkx2-5 extra-cardiac lineage and are analogous to those detected in extra-embryonic regions in chick embryos. We hypothesize that some Nkx2-5^+^ cells correspond to hemoangiogenic precursors that later populate the endothelium of yolk sac blood islands and hemogenic endocardium (our study and [@bib45]; [@bib70]).

Mouse Nkx2-5 lineage^+^ cells contribute to the hemogenic endothelium of the dorsal aorta {#s2-11}
-----------------------------------------------------------------------------------------

We next explored whether the mouse Nkx2-5 extra-embryonic lineage^+^ cells described above also contribute to the hemogenic endothelium of the AGM region in the DA. Nakano and colleagues did not detect Nkx2.5 lineage^+^ cells in the AGM at E9.5 using the crosses mentioned above ([@bib45]). However, in *Nkx2-5^irescre/+^;Rosa^YFP/+^* embryos at E10.5, we found abundant YFP^+^ cells in the AGM region, including in endothelium and sub-endothelium ([Figure 9I--J"'](#fig9){ref-type="fig"}; [Figure 9---figure supplement 1J--J'''](#fig9s1){ref-type="fig"}), as seen previously for cells in the AGM expressing the earliest hemogenic marker Runx1 ([@bib49]). We also saw cells with the same expression profile within the liver ([Figure 9K--K'''](#fig9){ref-type="fig"}), the first site of definitive mammalian embryonic hemopoiesis. Most YFP^+^ cells in the DA co-expressed Runx1, although there were also many Runx1^+^ YFP^-^ cells in the region ([Figure 9I--J'''](#fig9){ref-type="fig"}; [Figure 9---figure supplement 1I](#fig9s1){ref-type="fig"}). Quantifications showed that \~ 15% of Runx1^+^ cells in the endothelium and \~16% of Runx1^+^ cells in the sub-endothelium were also YFP^+^, while overall \>77% of YFP^+^ cells were also Runx1^+^ ([Figure 9---figure supplement 1I](#fig9s1){ref-type="fig"}). Consistently, we calculated a similar \~15% ratio of Runx1^+^/*Nkx2-5*-en^+^ in the chick DA (data not shown). Clusters of Runx1^+^ YFP^+^ cells appeared to be budding from the endothelial layer of the DA towards the lumen ([Figure 9J--J\'\'\'](#fig9){ref-type="fig"}, [Figure 9---figure supplement 1J--J\'\'\'](#fig9s1){ref-type="fig"}), behaviour consistent with that of hemogenic endothelium ([@bib23]). With a single exception, none of the YFP^+^ cells in the AGM expressed the hemogenic marker CD41 (integrin alpha2b) that is known to act downstream of Runx1 ([@bib40]). However, there were significant numbers of YFP^+^ CD41^+^ as well as YFP^+^ Runx1^+^ cells in the liver ([Figure Figure 9K-L\'\'\'](#fig9){ref-type="fig"}).

In line with previous mouse data ([@bib45]; [@bib51]; [@bib70]) and chick lineage tracing studies presented above, mouse Nkx2-5 lineage^+^ cells were detected within the endothelium of the pharyngeal arch arteries and paired dorsal aorta, and endocardium of the atria and ventricles, at E9.5 (data not shown) and E10.5 ([Figure 9---figure supplement 5A--E''](#fig9s5){ref-type="fig"}). Using *Nkx2-5^irescre/+^;Z/EG* embryos, we confirmed that Nkx2-5 lineage^+^ (GFP^+^) cells were embedded within Pecam1^+^ endothelium of the DA ([Figure 9---figure supplement 5E--E"](#fig9s5){ref-type="fig"}). Some Nkx2-5 lineage^+^ endothelial cells in the cardiac region at E10.5 were also CD41^+^, although these were very rare ([Figure 9---figure supplement 5C--D](#fig9s5){ref-type="fig"}).

Discussion {#s3}
==========

The present study provides novel insights into early cardiogenesis and hemangiogenesis in vertebrate embryos. First, we revealed an early contribution of mesodermal cells residing outside the classical cardiac crescent region, to the developing heart ([Figure 10](#fig10){ref-type="fig"}). Cellular and molecular analyses indicate that a subset of extra-embryonic/LPM-derived hemogenic angioblasts travels via the inflow tract to populate the heart endocardium. Moreover, our results in both chick and mouse models demonstrate that the hemogenic endothelium in the DA and endocardium derives, at least in part, from Nkx2.5 lineage^+^ angioblast progenitors that may also contribute to hematopoietic stem cells (HSCs) in the fetal liver ([Figure 10](#fig10){ref-type="fig"}). Based on these studies and gain of function experiments, we propose a broader role for Nkx2.5 in the cardiovascular and blood lineage diversification programs than currently appreciated.10.7554/eLife.20994.029Figure 10.*Nkx2.5* marks hemogenic angioblasts that contribute to the formation of the endocardium and dorsal aorta.Cardiovascular progenitors begin to form at the onset of gastrulaion. These populations segregate as the cells begin to migrate in a lateral fashion towards the extraembryonic tissue. During early gastrulation in the chick (St.4) or late gastrula stages in the mouse (cardiac crescent, E7.5) Nkx2.5^+^ hemogenic angioblasts are specified. While Nkx2.5 expression is maintained at the cardiac crescent its expression in the hemogenic angioblasts is downregulated. *Nkx2.5* lineage-derived cells populate the cardiac crescent, extraembryonic tissue and lateral plate mesoderm in both species (St.8 and E7.5). As the embryo develops *Nkx2.5* derived hemogenic angioblasts migrate to the endocardium and dorsal aorta, there generating blood cells via the hemogenic endothelium (St.18 and E10.5). In both chick and mouse *Nkx2.5* lineage derived cells contribute massively to the yolk sac vasculature and to HSCs in the fetal liver (mouse). CC -- cardiac crescent; DA -- dorsal aorta; EE -- extraembryonic; FHF -- first heart field; hrt -- heart; LB -- liver bud; LPM -- lateral plate mesoderm; PS -- primitive streak.**DOI:** [http://dx.doi.org/10.7554/eLife.20994.029](10.7554/eLife.20994.029)

The cardiovascular and hematopoietic lineage specification programs begin at gastrulation, when nascent mesodermal cells ingress through the primitive streak. In the chick, we demonstrated that Nkx2.5 is transiently expressed in the mid-primitive streak and the posterior LPM/extra-embryonic tissues at St. 4--6. Moreover, overexpression of Nkx2.5 induced endothelial/hematopoietic gene expression. In the mouse, *Nkx2-5* activation in extra-embryonic tissue occurred later in gastrulation than in the chick, at the time of cardiac crescent formation, but positive cells nonetheless contributed extensively to the yolk sac vasculature and blood. Expression was also seen in hemogenic endothelium of the AGM, although we have not yet shown definitively in mouse whether positive cells migrate to the AGM from extra-embryonic tissue or whether Nkx2-5 is expressed de novo in hemogenic angioblasts arising in embryonic LPM. Confirming findings of Nakano and colleagues ([@bib45]), we found Nkx2-5 lineage^+^ blood cells in the yolk sac and embryonic vessels. Nakano et al. found that Nkx2-5 lineage^+^ blood cells expressed haemoglobins typical of primitive then definitive erythropoiesis, although no positive blood cells were present in adults. These results resonate with those of Yoder et al., who demonstrated that the yolk sac contains HSCs capable of sustaining long-term multi-lineage hemopoiesis when transferred to conditioned hemopoietic organs of neonates although not adults ([@bib85]). Taken together our findings suggest that Nkx2.5 plays a conserved role in the establishment of the cardiovascular and early blood cell lineages, in apparent agreement with the severe defects observed in the yolk sac vasculature and hematopoiesis seen in *Nkx2-5* mutant mouse embryos ([@bib73]).

The electroporation technique in early chick embryos enabled us to follow nascent mesoderm progenitors with hemogenic angioblastic characteristics. What makes these cells hemangioblast-like? First, these extra-embryonic/LPM mesoderm progenitors were labelled by both *Nkx2-5-*en and hemangioblast enhancers. Morphologically, we observed the expression of these two enhancers within blood islands, and could track their migration into the DA (and other vessels), as well as to the endocardium. These cells broadly expressed hematopoietic and endothelial lineage markers such as *Runx1*, *Flk1*, *Tal1*, *Ets1*, *Gata1*, *Lmo2* and *Gata4*. When cultured *in vitro*, these cells differentiated into endothelial and blood progenitors, although we have not yet shown a bipotent differentiation potential in a clonal assay. Finally, we showed that in vivo, these cells contributed to the hemogenic endothelium in the DA and heart endocardium.

Tight molecular and cellular relationships exist between myocardial, endocardial, endothelial, and hematopoietic lineages in different organisms. A number of transcription factors control these cell fate choices, primarily through cross-inhibition mechanisms ([@bib6]; [@bib62]; [@bib80]). Heart, vessels and blood likely represent an ancient lineage triad controlled by Nkx2-5 that has contributed to cardiovascular and hemogenic developmental plasticity in vertebrates. This plasticity is highlighted by activation of the hematopoietic program within hemogenic endothelium at various embryonic sites, including the yolk sac ([@bib53]), DA ([@bib23]), extra-embryonic arteries ([@bib18]), and endocardium ([@bib45]).

The mouse enhancer for *Nkx2-5* labels a broad cardiovascular mesoderm population in the chick, including FHF cardiac progenitors, endothelial and hematopoietic progenitors. Because of the demonstrated early expression of Nkx2.5 protein and mRNA in the nascent mesoderm at St. 4--6, we suggest that the reporter expression provides a valid readout of the transient expression of *Nkx2.5* in these cells, which is later downregulated in extra-cardiac lineages by endothelial and hematopoietic transcription factors. In the mouse, we showed that *Nkx2-5* lineage^+^ cells arise in extra-embryonic tissues later in gastrulation associated with cardiac crescent formation. Linage^+^ cells also contributed substantially to the hemogenic endothelium within the AGM, liver, and, to a lesser degree, the endocardium. The extra-cardiac Nkx2-5 lineage^+^ cells that contribute to mouse hemopoiesis in the embryo from E8.5-E15.5 ([@bib45]), likely derive from the yolk sac or AGM region via the liver, rather than the endocardium as proposed ([@bib45]). However, whether there is a contribution of Nkx2-5 lineage^+^ cells to primitive hemopoiesis in the mouse yolk sac, and how Nkx2-5 lineage^+^ cell arrive in the AGM region, remain to be explored. Moreover, how Nkx2-5 lineage^+^ cells relate to the Runx1^+^ Gata1^-^ Etv2^+^ VE-cadherin^+^ hemogenic angioblasts which are already present in the yolk sac at E7.5 ([@bib15]; [@bib33]; [@bib75]), needs detailed analysis. Notwithstanding the differences in the timing of activation of Nkx2-5 in extraembryonic tissue in chick and mouse, our findings on the Nkx2-5 lineage in these two models seem highly concordant.

Bioinformatics and *in vitro* analyses demonstrated that several *Gata* and *Ets* sites are present and active within the *Nkx2-5* enhancer (data not shown and [@bib34]). Our ISH and RT-PCR analysis revealed the expression of *Gata4* in both LPM and cardiac crescent (and also nascent mesoderm) corresponding to the expression of the *Nkx2-5*-en. Hence, Gata factors could drive the early expression of *Nkx2.5*. Scl/Tal1 was previously shown to be a key regulator of hemangioblasts ([@bib5]; [@bib62]; [@bib80]). Our findings demonstrating the ectopic activation of *Tal1* by Nkx2.5 suggest that the latter acts upstream of Tal1 in the hemangioblast hierarchy and may have a role in priming hemopoiesis. Activation of Tal1 in the chick inhibited cardiac gene expression, in line with the repressive role of Scl/Tal1 on cardiogenesis, as demonstrated in Scl/Tal1 mutant mouse embryos in which ectopic cardiomyogenesis was observed in the yolk sac vasculature and endocardium ([@bib80]). Similar to Scl/Tal1, loss of etsrp/etv2 induced cardiac gene expression in endocardial progenitors ([@bib52]; [@bib57]). Taken together, these studies and our data highlight the dynamic developmental interplay between embryonic mesoderm progenitors for cardiac, endothelial and blood lineages.

Endocardial cells are known to be heterogeneous in origins ([@bib20]; [@bib41]; [@bib81]). *In vitro* studies in chick and mouse provided evidence for bipotential progenitors for myocardial and endocardial cells that exist in the SHF ([@bib22]; [@bib24]; [@bib31]; [@bib43]), but probably not in the FHF in which myocardial progenitors are unipotent ([@bib31]; [@bib67]). Our findings are consistent with the idea that endocardial and myocardial lineage separation occurs very early during embryogenesis, in line with other studies ([@bib32]; [@bib41]; [@bib51]).

Understanding the origin and regulation of definitive HSCs is a subject of great interest and contention. It is clear that HSCs are mesoderm-derived and their genesis involves differentiation from endothelial cells. In the chick, zebrafish and mouse embryos, the splanchnic mesoderm has been considered to be the source of hemogenic endothelium-derived HSCs ([@bib9]; [@bib29]; [@bib87]). More recent data suggest that hemogenic endothelium at embryonic sites have their origins in the yolk sac ([@bib75]). It is likely that multiple sources of endothelial cells contribute to the formation and establishment of HSCs including extra-embryonic hemogenic angioblasts ([@bib75]) and intra-embryonic angioblasts that are induced to form HSCs by local signalling ([@bib47]; [@bib58]). Consistent with these findings we suggest that part of the hemogenic endothelium in both DA and endocardium derives from extra-embryonic/LPM hemogenic angioblast progenitors previously expressing Nkx2.5. The detection of Nkx2.5 lineage^+^ hematopoietic progenitors in DA, liver and endocardium, suggests that these progenitors derive from a common embryonic origin, although this remains to be formally tested. Potentially relevant to this work, a lineage tracing study with *Nfatc1-Cre* mice suggests that endocardial cells, which are in contact with liver epithelium, contribute to the liver vasculature ([@bib86]).

As in the DA, endocardial cells have multiple origins, some of which derive from specialized angioblasts with hemogenic properties. Indeed, the existence of specialized angioblasts has now been documented in the floor of the cardinal vein that generates lymph, arterial and venous cell fates ([@bib48]). Thus, analysis of heart development has revealed on the one hand major contributions from the well-characterised cardiac cell populations (e.g. FHF, SHF, cardiac neural crest, epicardium), along with minor contributions from other mesodermal progenitors that provide further developmental plasticity and functionality.

Our studies and those of others (see Introduction) suggest a conserved role for Nkx2.5 in both heart and hemoangiogenic lineage development. In addition to its role in the specification of cardiac mesoderm, the *Drosophila* Nkx2.5 homologue, tinman, is essential for formation of the fly larval lymph gland, a hemopoietic organ proposed to be similar to the hemogenic endothelium of the mammalian AGM region ([@bib37]). Thus, cardio-hemoangiogenic lineage development may be one of the ancestral functions of Nkx2.5. In summary, the role of Nkx2.5 in endothelial and blood specification programs is evolutionarily conserved from fly to human. In vertebrates, Nkx2.5 expression is mostly restricted to cardiac progenitors, but in a narrow window of time may prime vascular and blood development, as shown already in pharyngeal arch arteries and endocardium ([@bib45]; [@bib51]). The definitive vasculature and blood networks ultimately utilise other transcription factors for lineage specialisation, which also prevent ectopic heart formation in these highly plastic mesodermal cells ([@bib80]). Unravelling the dynamic roles of Nkx2.5 in cardiac, endothelial, and blood lineage specification will lead to a deeper understanding of the cardiovascular/blood regulatory networks, and may point the way toward novel regenerative therapies for cardiovascular disease.

Materials and methods {#s4}
=====================

Eggs and embryos {#s4-1}
----------------

Fertilized white eggs from commercial sources were incubated to the desired stage at 38.0°C in a humidified incubator, according to Hamburger and Hamilton ([@bib19]).

Mouse lines {#s4-2}
-----------

Mice used in this study were bred and maintained in the Victor Chang Cardiac Research Institute BioCore facility according to the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. For the *Nkx2-5*-lineage study, the *Nkx2-5^irescre^* strain ([@bib70]) was crossed with *Rosa^lacZ^* ([@bib66]), *Rosa^YFP^* ([@bib68]) or *Z/EG* ([@bib50]) reporter lines. Litters of required embryonic stages were dissected in 1X ice cold PBS, fixed and processed accordingly.

Whole mount β-Gal staining {#s4-3}
--------------------------

For whole mount β-gal staining, embryos were fixed in 0.1 M sodium phosphate buffer containing 0.2% glutaraldehyde, 1.48% formaldehyde, 5 mM EGTA and 2 mM magnesium chloride, pH7.3 from 30 min to 60 min at room temperature depending on the size of the embryo (for examples, E9.0 embryos were fixed for 1 hr). Further, embryos were washed in 0.1M sodium phosphate buffer containing 2 mM of magnesium chloride, 0.01% sodium deoxycholate and 0.02% of Nonidet-P40 detergent followed by β-gal staining in 0.1M sodium phosphate buffer containing 1X potassium ferrocynide, 1X potassium ferricynide and 1 mg/ml of X-gal (Promega, V3941). Imaging of whole mount beta-gal stained embryos was done with Leica M125 microscope fitted with a Leica DFC295 camera.

Mouse sectioning and immunostaining {#s4-4}
-----------------------------------

Embryos were fixed in 4% PFA at 4° C overnight followed by PBS washes. Subsequently, embryos were transferred through a 15% and 30% sucrose gradation followed by embedding in Tissue-Tek O.C.T. compound (Thermo scientific, Waltham, MA USA). 10 μM sections were prepared using Leica cryostat. For immune-staining sections were fixed in 4% PFA for 5 min on ice, washed in a 1X PBS, blocked in serum containing 3% goat serum, 3% bovine serum albumin and 0.1% Triton X-100 followed by incubation with primary antibodies overnight at 4° C. Primary antibodies used were GFP (1:200, ab13970), Runx1 (1:200, ab92336), CD41 (1:300, ab33661), CD31 (1:100, 553370, BD Pharmingen), Vegfr2/Flk1 (1:100, sc48161) and VE-cadherin (1:100, sc-6458). Secondary antibodies, anti-rabbit biotin, anti-rat biotin, anti-goat biotin and anti-chicken Alexa Fluor-488 (Life Technology) were used at 1:200 concentrations. For biotinylated antibodies signal was amplified using ABC (Vectastatin) and cy3-Tyramide amplification kit (Perkin Elmer). Images were taken using a Zeiss LSM 700 Upright confocal microscope.

Quantification of Nkx2-5 lineage cells in mouse AGM {#s4-5}
---------------------------------------------------

Runx1^+^ YFP^-^, Runx1^-^ YFP^+^ and Runx1^+^ YFP^+^ cells were quantified in endothelium or sub-endothelium of the DA in the region of AGM from three different embryos. Confocal Z-stack images from six to eight 10 µm sections per embryo were used for counting. The average number of single or double positive cells per section were graphed with standard deviation.

Whole mount in situ hybridization {#s4-6}
---------------------------------

Whole mount in situ hybridization was performed, using digoxigenin (dig)-labelled antisense riboprobes synthesized from total cDNA. Briefly riboprobes were generated using T7 polymerase in the presence of dig-labelled UTP (Roche, Penzberg, Germany). Embryos were incubated to the desired stage, and fixed in 4% paraformaldehyde (PFA) overnight. Dehydration was performed with methanol series, after which the embryos were stored in absolute methanol overnight at −20°C. Rehydration was performed in methanol series, in PBT. Embryos were treated with proteinase K and fixed with 4% PFA/0.2% glutaraldehyde. Prehybridization (50% formamide, 5XSSC pH 4.5, 2% SDS, 250 μg/ml yeast tRNA, 50 μg/ml heparin) was performed at 68°C, prior to hybridization overnight at that temperature. To remove unbound probe, a series of washes (50% formamide, 5XSSC pH 4.5, 1% SDS) was performed. After a second series of washes in 0.1M maleic acid (Ph 7.4), 0.15M NaCl, and 1% Tween-20 (MABT), the embryos were incubated in blocking solution (20% whole goat serum in MABT) for 2 hr; an anti-dig alkaline phosphatase-conjugated antibody (Roche) was then added to the blocking solution, and embryos were incubated at 4°C overnight. A colour reaction was performed using NBT/BCIP substrates (Roche). To stop the reaction, embryos were fixed in 4% PFA.

Chick sectioning and immunostaining {#s4-7}
-----------------------------------

For wholemount immunostaining St.3--4 embryos were dissected with their yolk sac, fixed in 4% PFA for 1 hr and then subjected to standard immunostaining protocol. For cryo-sections, embryos were fixed in 4% PFA, incubated overnight in 30% sucrose in PBS at 4°C and then embedded in a Peel-A-Way plastic mold (VWR, Radnor, PA USA) in OCT compound (Sakura, VWR). The embryos were sectioned between 7--15 μm, using a Leica cryostat. Sections were blocked with 5% whole goat serum in 1% bovine serum albumin in PBS, prior to incubation with primary antibodies. We used the following primary antibodies: Nkx2.5 (1:300, Santa-Cruz SC-8697) was amplified using the Tyramid amplification kit (Perkin-Elmer Waltham, MA USA and Life Technologies, Carlsbad, CA USA). Isl1 (DSHB, 40.3A4, 1:5), CD45 (1:100, Prionics HIS-C7), Runx1 (1:100, Abcam ab92336), EGFP (1:100, Santa Cruz SC-101536), and a novel in-house Cdh5 (1:100, VE-cadherin). Secondary antibodies: Cy2/488, Cy3/594 and Cy5/647-conjugated anti-mouse, anti-rabbit, anti-rat IgG (Jackson ImmunoResearch laboratories, West Grove, PA USA and Thermo Fischer) were diluted 1:100.

Chick imaging and time-lapse microscopy {#s4-8}
---------------------------------------

Images are obtained using a Leica MZ 16FA stereomicroscope attached to a Leica digital camera (DC300F, Leica Microsystems, Wetzlar, Germany) and an assembled upright fluorescent microscope (Nikon ECLIPSE 90i) with a CCD camera. For time lapse filming a temperature controlled chamber (semi-automated) is used under the software advanced acquisition system (Image-Pro AMS version 6.0, Media Cybernetics, Bethesda, MD, USA). The system allows multi channel (bright field and GFP ) Z-stacks (for constructing a focused image) photography at multi time points for generating a time lapse movie. Cell tracking in live embryos was performed by manual analysis of 7 focal planes at each time point during *in vivo* imaging. Time lapse imaging was also performed using the DeltaVision Elite system (Applied Precision, USA), on an Olympus IX71 inverted microscope, running softWoRx 6.0 by a CoolSnap HQ2 CCD camera (Roper Scientific, USA). Still images were also obtained with the Zeiss Cell Observer Spinning Disk Confocal microscope (Oberkochen, Germany). Captured images were analyzed by ZEN, Photoshop, Image-Pro AMS and ImageJ softwares.

*Ex ovo* electroporation {#s4-9}
------------------------

To introduce DNA vectors into the embryonic mesoderm, a method was used involving electroporation of mesodermal cells while they are still epithelial, prior to their ingression during gastrulation. Chick embryos were cultured in 'EC-culture' ([@bib8]). Embryos were then placed ventral side up (the vitelline membrane on the bottom) above the cathode, made of a 2 × 2 mm platinum plate located in a concavity made in the plastic platform. A solution of 1 μg/μl DNA and Fast Green (10 μg/ml) was injected between the blastoderm and the vitelline membrane, using a glass capillary. An anodal electrode, with an inter-electrode distance of 4 mm, was quickly placed on the hypoblast side of the embryo, and electroporation was performed using an ECM830 electroporator (BTX Co. Ltd, Holliston, MA USA). St. 3 embryos were electroporated with 3 pulses of 9V each, for 35 ms at intervals of 300 ms. After electroporation was complete, embryos were transferred back to the EC culture plates, and incubated to the desired stage.

Reporter and over-expression plasmids {#s4-10}
-------------------------------------

A novel *Isl1* cardiac enhancer was identified, using comparative genomic analysis (genomes of chick, rat, zebrafish and human were used). The enhancer was cloned into previously described pTK vectors that contain a minimal promoter from the HSV *thymidine kinase* gene upstream of GFP/RFP, and were shown to be permissive for enhancer activity in chick embryos ([@bib79]). Control vectors for broad expression within the embryo, the reporter plasmids pCAGG-GFP/RFP, which were previously described ([@bib46]), were injected. The mouse *Nkx2-5* cardiac enhancer was obtained from Prof. Eric Olson ([@bib34]) and subcloned into the pTK vector for chick expression. To study the relationship between the hemangioblast and the cardiac mesoderm, we obtained a hemangioblast enhancer based on the chick *Cerberus* gene, that drives expression of GFP ([@bib76]). For ectopic expression of Nkx2.5 and Tal1, chick coding sequences were cloned into pCAGG-IRES-GFP, which drives ubiquitous expression in every avian cell ([@bib38]).

Explants and RNA analysis {#s4-11}
-------------------------

Dissection of different explants from chick embryos was carried out using a tungsten needle. Explants were isolated together with all germ layers at selected embryonic stages and locations. Posterior LPM explants were cultured for 4.5 days on a collagen drop covered with 700 μl of dissection medium (10% Fetal Calf Serum, chick embryo extract 2.5% and pen/strep 1% in αMEM medium, Biological Industries, Israel) in a four-well plate. Total RNA was extracted using Qiagene RNeasy Micro Kit (Qiagen, Germany), followed by reverse transcription using the cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA USA). The cDNA product was then amplified using different sets of primers, via semi-quantitative RT-PCR. The RNA analysis was performed using semi-quantitative RT-PCR with Green Master Mix (Promega, Madison, WI USA).

Primers used for semi-quantitative RT-PCR {#s4-12}
-----------------------------------------

  **Primer name**   **5\' seq**              **3\' seq**
  ----------------- ------------------------ -----------------------
  Bry-qpcr          ACGCCATGTACTCCTTCCTG     TGTTGGTGAGCTTGACCTTG
  CD31-qpcr         TGTGGAAGCAGGTGGAAAGA     CACTTCTTCTGGCAGCTCAC
  Ets1-qpcr         TCAGTCATCCTTCGTGACCC     CCACCCAGTTTACCTCGACT
  Flk1-qpcr         GGAGGACGCTGGTTCTGAAG     ATGTCTCGAGCCAAGCCAAA
  Gata1-qpcr        AGACATCCACCACCACTCTG     GTTTCGGGTTTGGATTCCGT
  Gata4-qpcr        TCCTACTCCAGCCCTTACCC     AAAAATTCTGCGATGTTGGCA
  Isl1-qpcr         TGCAGATGGCAGCAGAACCT     TGCTCTTTCATGAGGGCGTC
  Mesp2-qpcr        GGTCATCACCCTCCTACAGC     TCTGCATCCACAAAGTCTGG
  Nkx2.5-qpcr       AGGCGGACAAGAAAGAACTG     CCAGTTCGTAGACTTGGGCT
  Runx1-qpcr        TCCTACCAGTACCTGGGCTC     GTCAGAAGCACCTGAGAGGC
  Tal1-qpcr         TCTTGCGCCTGGCTATGAAA     GAGCTTCCACAGCTGGAGTT
  Tbx5-qpcr         GGCGAAGGAAGCTCGTAACA     ACTTTGATCCCCTCCATGCC
  GAPDH-qpcr        AGAACATCATCCCAGCGTCCAC   ACGGCAGGTCAGGTCAACAAC

Analysis of single cell transcriptome data {#s4-13}
------------------------------------------

Gene-level read counts data from single cell RNA-seq of single cells from E7-0-7.75 mouse embryos ([@bib65]) were downloaded from <http://gastrulation.stemcells.cam.ac.uk.> Read counts were normalized for sequencing depth using size factors calculated with DESeq ([@bib1]). Only samples from E7.0-E7.75 stage embryos were used. t-SNE plots were generated with highly variable genes as described ([@bib65]). Single cell RNA-seq samples were categorized as expressing *Nkx2-5* if they had normalized read counts \> 1/cell.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled \"Nkx2.5 marks hemangioblast progenitors that contribute to the formation of hemogenic endothelium in the heart\" for consideration at *eLife*. Your full submission has been evaluated by Janet Rossant (Senior Editor), a Reviewing Editor, and two peer reviewers, and the decision was reached after discussions between the reviewers. Based on our discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The reviewers found the overall study to be potentially interesting and provocative, with the suggestion that both hemogenic endocardium in the heart and hemogenic endothelium in the dorsal aorta derive from Nkx2.5 expressing mesodermal cells. However, the reviewers were not convinced that the data as presented are sufficient to support this conclusion, without direct lineage tracing experiments. They also noted worrying inconsistencies between the labeling by *Nkx2.5-en* and in situ hybridization by Nkx2.5 in the LPM. At this stage, a more definitive study with different experimental approaches would be required before we could consider another version. The full reviews with suggestions for further studies are appended below.

*Reviewer \#1:*

This work investigates mesodermal progenitor specification and migration during the development of the cardiovascular and blood systems. The authors use known and novel cardiovascular enhancers to activate reporter gene expression in avian embryos and follow the migration of distinct mesodermal populations over time. The most novel aspect of the study is the finding that some endocardial cells derive from a separate mesodermal origin outside the heart. More specifically, the authors propose that this extraembryonic mesoderm derived population gives rise to hemogenic endocardium, which has been recently described in the heart. This is a potentially novel finding that advances the field. The authors propose that both hemogenic endocardium in the heart and hemogenic endothelium in the dorsal aorta derive from Nkx2.5 expressing mesodermal cells (\"hemangioblasts\") and propose a model in which transient expression of Nkx.5 activates a hemato-vascular program, while sustained expression leads to cardiomyocyte development.

Although these findings are of potential interest and importance, it is sometimes difficult to follow the IF figures, and some data regarding the major conclusions require clarification. As an example, there is discrepancy between the enhancer activity and mRNA and protein expression that is not fully clarified. Also, the data that Nkx2.5 expressing cells form hemogenic clusters in the endocardium is not clear based on the figures. It is also not clear from the description and data how the migration of the Nkx2.5 derived cells to the heart occurs. Another potential weakness is that the paper is largely descriptive rather than mechanistic, although the authors do show that early overexpression of Nkx2.5 can induce broadly a hemato-vascular expression program. Moreover, they show that Tal1/Scl, a blood specification factor that is also induced by Nkx2.5 overexpression in this system, represses cardiomyocyte specification in a subset of mesodermal cells, although the finding that Tal1 represses cardiomyocyte development is not entirely new.

Thus, this manuscript is of potential interest, but can be fully evaluated only once these issues have been attended to.

*Reviewer \#2:*

This is an interesting manuscript. The main claim of this paper is that Nkx2.5 expression marks mesodermal progenitors that contribute to the formation of hemogenic endothelium in the heart and AGM.

The data presented in this manuscript are not sufficient to support this claim. The authors demonstrate that LPM cells marked with *Nkx2.5-en* migrate to the heart and to the dorsal aorta. They also demonstrate that some cells labeled by Hb-en are also marked by *NKx2.5-en* in the LPM and that Hb-en marks hemogenic endothelium and blood in the AGM and the heart. However, there is no direct evidence that the cells co-labeled by Hb-en and *NKx2.5-en* in the LPM are the ones that contribute to blood formation in these regions. Also, the absence of correlation between the labeling by *Nkx2.5-en* and in situ hybridization by Nkx2.5 in the LPM is worrisome.

Nkx2.5 genetic lineage tracing experiments would be required to definitively prove that Nkx2.5 transient expression marks mesodermal progenitors that contribute to the formation of hemogenic endothelium in the heart and AGM. Importantly, to demonstrate that primitive streak derived hemangioblasts give rise to hemogenic endothelium in the AGM, continuous time lapse imaging should be performed.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your article \"Nkx2.5 marks angioblasts that contribute to hemogenic endothelium of the endocardium and dorsal aorta\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Zamir et al. show that Nkx2.5 expressing mesodermal precursors in the lateral plate mesoderm and the yolk sac give rise to a subpopulation of endocardial cells, as well as to hemogenic endocardium and hemogenic endothelium in the dorsal aorta. The data are derived from genetic lineage tracing in mouse embryos, as well as lineage tracing via expression of a GFP-tagged mouse Nkx2.5 enhancer in chick embryos. Both approaches provide converging evidence that supports the conclusion.

Essential small, but important, revisions and minor points:

There are a number of recommendations concerning data presentation and edits that should be made before the final manuscript is accepted.

*Reviewer \#1 (Minor comments):*

1\) [Figure 2](#fig2){ref-type="fig"}: The images are a little difficult to interpret. Higher magnification images would support the claim that the cells in the populations are mNkx2.5-en and mlsl1-en double positive or single positive. Also, labelling regions such as cardiac crescent, area vasculosa and heart tube etc. would enhance readability.

2\) Introduction, second paragraph: some references are missing and it would be more precise to write: However, while blood cell formation from \"hemogenic endothelium\" has been visualised directly in multiple animal models (Boisset et al., 2010; Lam et al., 2010, Bertrand 2010, Kissa 2010), and in vitro during ES cells differentiation (Eilken et al., 2009; Lancrin 2009), the existence in vivo of a bipotential hemangioblast that contributes to both blood and endothelial cells remains controversial (Hirschi, 2012).

3\) I am not sure why the authors do not call their Nkx2.5 cell population a hemangioblast population as these cells in nascent mesoderm are able to form both endothelial and blood cells as stated in the abstract (although it is not shown at a clonal level). Also, the authors do not present enough data to claim that they uncovered a novel role of Nkx2.5 (Abstract and end of the Introduction), the data presented are mostly descriptive and establish mainly that Nkx2.5 is expressed in hemangioblast. The Abstract and text should be changed accordingly. I would propose for the Abstract \"Taken together, we identified a hemangioblast cell lineage characterized by transient Nkx2.5 expression that contributes to hemogenic endothelium and endocardium, uncovering Nkx2.5 as a novel marker of hemangioblast lineage specification and diversification.\"

4\) When the authors discuss in the second paragraph of the Introduction and in the fifth and eighth paragraphs of the Discussion, the migration of hemogenic endothelium precursors to different embryonic sites of hematopoiesis (Tanaka 2014), they should also mention the recent paper by Eliades 2016 (PMID:27239041). Also, it would be interesting to mention the potential role of RUNX1 in cell migration/adhesion (PMID:25082880). Finally, the meaning of the last sentence of this paragraph is not clear: Runx1 is essential at this early stage for priming the establishment of hemogenic endothelial cell fate in the aorta-gonad-mesonephros (AGM) region, where Runx1 is also activated, and for definitive hemopoiesis (Tanaka et al., 2012).

5\) Please rename the video titles so that they fit the video titles in the manuscript text.

6\) [Figure 4H](#fig4){ref-type="fig"}. Can the authors supply single channel images to support the claim of Hb-en and mNkx2.5-en double positive cells in the endocardium?

7\) [Figure 5D](#fig5){ref-type="fig"}. Only a single RUNX1+/Nkx2.5 en+ cell is shown. What percentage of RUNX1+ HE cells found at this stage in the dorsal aorta are Nkx2.5en+?

8\) [Figure 7D](#fig7){ref-type="fig"}: Mouse Nkx2.5 lineage+ cells contribute to yolk sac vasculature. Pecam1 staining is required to confirm the endothelial nature of the Nkx2.5 lineage+ cells associated with the yolk sac vasculature.

9\) Do the Nkx2.5 expressing cells detected in E7.5 murine nascent mesoderm (Figure 7---figure supplement 2) also express hematopoietic or endothelial markers?

10\) [Figure 8B](#fig8){ref-type="fig"} the expression of RUNX1 and Tal1 is not obvious.

11\) Discussion, first paragraph: are the authors claiming the presence of hemogenic endothelium in the liver? This is not supported by any data.

12\) Subsection "Mouse Nkx2-5 lineage^+^ cells contribute to yolk sac vasculature", last paragraph: Typo misspelling of \'lineage\'

13\) Subsection "Nkx2.5 is expressed in the nascent mesoderm in the primitive streak of chick embryos", second paragraph: Typo misspelling of \"immunofluorescence\"

14\) Subsection "Ectopic expression of Nkx2.5 induces hemangioblast gene expression", last paragraph: Typo misspelling of \'definitive\'

*Reviewer 2 (Minor comments):*

1\) The authors should start the paper with the mouse data, which they then confirm using expression of the mouse enhancer in chick embryos. This would make the paper somewhat easier to read, as in the current version they switch from chick to mouse then back to chick.

2\) Question regarding the mouse data: [Figure 7I and J](#fig7){ref-type="fig"} show that the majority of YFP cells in the DA are also Runx1+. However, this is not reflected in the quantification in Figure.7---figure supplement 1I. Please clarify.

3\) Current [Figure 1](#fig1){ref-type="fig"} starts off with an Isl1 enhancer, which is really used as a negative control. The data should be reorganized to start off with the Nkx2.5 enhancer that they use to drive GFP expression in chick embryos. Panel J reads Isl1-en I suppose this should read Nkx2.5-en. There are several J\' panels. Overall, figure legends should be matched to Figures ([Figure 6](#fig6){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} Figure are other examples!).

4\) Do the authors claim that the mouse enhancer is sufficient to drive Nkx2.5 expression in hemogenic endothelium and endocardium? Please comment.

5\) Data in [Figure 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"} use electroporation with a GFP-tagged Cerberus hemangioblast enhancer Hb-en as a positive control. I find co-localization of Hb-en and Nkx2.5-en in [Figure 3](#fig3){ref-type="fig"} convincing, but data in [Figure 4](#fig4){ref-type="fig"} should track double-labeled Hb-en and Nkx2.5-en cells, or at least single labeled Nkx2.5+ cells! Likewise, explant data in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} should use both Nkx2.5-en and Hb-en.

6\) Do Nkx2.5+ cells contribute some or all of the hemogenic endothelial cells in the DA and endocardium? And when and how do they get to that location? Please discuss.

10.7554/eLife.20994.035

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*Reviewer \#1:*

*\[...\] Although these findings are of potential interest and importance, it is sometimes difficult to follow the IF figures, and some data regarding the major conclusions require clarification.*

We have improved and replaced many of the figures. In fact, [Figures 4](#fig4){ref-type="fig"}--[8](#fig8){ref-type="fig"} and their corresponding figure supplements have been modified in the revised manuscript. Additional results were added (e.g., the contribution of the Nkx2.5 lineage in mice to both dorsal aorta (DA), liver and heart endocardium; new [Figure 7](#fig7){ref-type="fig"} and associated supplementary figures). Labeling of the figures was also improved.

*As an example, there is discrepancy between the enhancer activity and mRNA and protein expression that is not fully clarified.*

We have expanded our temporal gene expression analysis of Nkx2.5 (RNA and protein) in both chick and mouse embryos in various mesoderm populations at different stages ([Figures 7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}, Figure 7---figure supplement 1-3, [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Importantly, whole-mount immunostaining on gastrulating St. 4 chick embryos revealed clear expression of Nkx2.5 protein in and outside the primitive streak when newly formed mesoderm cells arise ([Figure 8](#fig8){ref-type="fig"}). In addition, we have performed extensive lineage tracing experiments in mice using the Nkx2-5^IRESCre^ driver line ([Figure 7](#fig7){ref-type="fig"}, Figure 7---figure supplement 1-3), which, combined with expression analysis using Nkx2-5*^lacZ^* knockin mice, reveal the origins or extracardiac Nkx2-5 lineage^+^ cells. This has not been revealed in previous studies. These experiments performed in E7.0-10.5 embryos recapitulate most of the data obtained in the chick using the Nkx2.5 enhancer (new [Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Although the timing of the first appearance of Nkx2-5 lineage^+^ cells in extraembryonic mesoderm differs somewhat between chick and mouse, our experiments are highly concordant. We document that Nkx2.5 expressing cells label two mesoderm populations in E7.5 mouse embryos: 1) Cardiac progenitors within the cardiac crescent and 2) angioblasts scattered throughout the LPM and yolk sac.

Importantly, at E9.5-10.5, the majority of the yolk sac vasculature as well as hemogenic endothelial cells in the DA, liver and heart could be traced to the extracardiac Nkx2.5 lineage^+^ cells in the mouse. Based on the chick and mouse data sets we conclude that the mouse extracardi Nkx2-5^+^ cells are analogous to those detected in extraembryonic/LPM cells in chick embryos and represent hemo-angiogenic precursors that later populate the endothelium of yolk sac vasculature, and hemogenic endothelium. Thus, the Nkx2.5 enhancer system in the chick serves as a valid lineage-tracing tool to label a population of mesoderm progenitors that transiently express Nkx2.5. We discuss the temporal differences between the mouse and chick data.

*Also, the data that Nkx2.5 expressing cells form hemogenic clusters in the endocardium is not clear based on the figures. It is also not clear from the description and data how the migration of the Nkx2.5 derived cells to the heart occurs.*

To address this issue we have performed additional experiments in chick embryos with the *mNkx2.5*-en. Embryos expressing the enhancer were analyzed for expression in both heart and DA. *mNkx2.5*-en^+^ cells expressing endothelial and blood markers (Cdh5, Runx1, CD45) were detected in the endocardium and DA. Additional IF panels of the *Nkx2.5 enhancer* expression along with Cdh5, Runx1, and CD45 were added see ([Figures 5](#fig5){ref-type="fig"}--[6](#fig6){ref-type="fig"}).

The migration pattern of these *mNkx2.5*-en^+^ hemogenic angioblasts could be visualized in the new supplementary movies ([Videos 1](#media1){ref-type="other"}--[3](#media3){ref-type="other"}). Furthermore, lineage tracing experiments in the mouse revealed the contribution of the Nkx2-5 lineage to hemogenic endothelium in the DA, and heart as shown by immunostaining for hemogenic markers ([Figure 7](#fig7){ref-type="fig"} and Figure 7---figure supplements 1-3). Interestingly, hemogenic cells from the Nkx2.5 lineage were also detected in the liver, a bona fide organ for embryonic hematopoiesis ([Figure 7](#fig7){ref-type="fig"}).

The migration of the cells into the heart is independent of circulation as it starts around St. 5-7, prior to the formation of the primitive heart tube. Analysis of the time-lapse movies suggests that in St. 7 chick embryos there are distinct cell populations that contribute to specific parts of the heart. Cardiac progenitors within the cardiac crescent maintain their relative anterior-posterior axis in the fused heart tube \[consistent with previous findings (Wei and Mikawa, 2000)\].

The migration pattern of the hemo-angiogenic precursors can be seen in the [revised]{.ul} [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} where a single cell can be traced migrating towards the inflow tract. High magnification images were added to this figure improving single cell track resolution.

*Another potential weakness is that the paper is largely descriptive rather than mechanistic, although the authors do show that early overexpression of Nkx2.5 can induce broadly a hemato-vascular expression program.*

We agree with this assessment although the primary purpose of this paper is to establish the basis for further mechanistic studies from careful lineage tracing data. Having said that, the gain of function data presented in [Figure 9](#fig9){ref-type="fig"} as well as in [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"} and [2](#fig9s2){ref-type="fig"}, are novel and striking, and establish that transient expression of Nkx2.5 in the primitive streak in chick is likely to be functionally important for hemoangiogenesis. We show that Nkx2.5 overexpression induces a set of endothelial/blood markers including *Tal1, Flk1, Ets1 and Lmo2*. Hence Nkx2.5 can induce hemato- vascular gene expression in-vivo.

*Moreover, they show that Tal1/Scl, a blood specification factor that is also induced by Nkx2.5 overexpression in this system, represses cardiomyocyte specification in a subset of mesodermal cells, although the finding that Tal1 represses cardiomyocyte development is not entirely new.*

We agree that these results support the loss of function studies of Tal1/Scl in mice, in which there was ectopic cardiogenesis (Schoenebeck et al., 2007; Van Handel et al., 2012). However, to our knowledge, the effect of Tal1 overexpression in vivoon cardiac development has not been described before. The perturbation of the cardiovascular system by Tal1 overexpression was manifested by a set of defects in heart tube formation leading to edema. The effect of Tal1/Scl on cardiogenesis is still unclear as a very recent Nature paper argues against the repressive role of Scl1/Tal1 on cardiogenesis (Scialdone et al., 2016). However, as noted, our experiment is complementary to the genetic loss of function data in mice. We included these data as supplementary information in order to validate the specificity of, and contrast the novel findings obtained in, the Nkx2.5 overexpression experiment.

*Reviewer \#2:*

*This is an interesting manuscript. The main claim of this paper is that Nkx2.5 expression marks mesodermal progenitors that contribute to the formation of hemogenic endothelium in the heart and AGM.*

*The data presented in this manuscript are not sufficient to support this claim. The authors demonstrate that LPM cells marked with Nkx2.5-en migrate to the heart and to the dorsal aorta. They also demonstrate that some cells labeled by Hb-en are also marked by NKx2.5-en in the LPM and that Hb-en marks hemogenic endothelium and blood in the AGM and the heart. However, there is no direct evidence that the cells co-labeled by Hb-en and NKx2.5-en in the LPM are the ones that contribute to blood formation in these regions. Also, the absence of correlation between the labeling by Nkx2.5-en and in situ hybridization by Nkx2.5 in the LPM is worrisome.*

*Nkx2.5 genetic lineage tracing experiments would be required to definitively prove that Nkx2.5 transient expression marks mesodermal progenitors that contribute to the formation of hemogenic endothelium in the heart and AGM. Importantly, to demonstrate that primitive streak derived hemangioblasts give rise to hemogenic endothelium in the AGM, continuous time lapse imaging should be performed.*

We thank the reviewer for his assessment of the work.

As indicated above and in response to this reviewer's comments we now provide additional experiments in support of our work in chick embryos by adding an extensive set of lineage tracing experiments in the mouse done in collaboration with Richard Harvey's lab demonstrating the contribution of extra-cardiac Nkx2.5 lineage^+^ cells to the yolk-sac vasculature as well as to the hemogenic endothelium in the dorsal aorta and the liver ([Figure 7](#fig7){ref-type="fig"}) as well as to the endocardium ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Sensitive expression analysis using Nkx2-5^LacZ^ knockin mice, and embryo topographical RNAseq data (in collaboration with Patrick Tam and colleagues) were also performed. Regarding the lack of correlation between the enhancer and protein expression, we now show Nkx2.5 immunostaining demonstrating expression in the nascent mesoderm in and outside the primitive streak of St. 4 chick embryos ([Figure 8](#fig8){ref-type="fig"}). We hope that the lineage tracing and expression data in the mouse coupled with the new protein expression data showing the presence of Nkx2.5 in the nascent mesoderm of gastrulating chick embryos, addresses the major concerns of this reviewer.

For technical reasons, we could not show a single cell labeled by both enhancers in the LPM that goes on and form blood cells. However, we do show that mouse extra-cardiac Nkx2-5 lineage^+^ cells form circulating blood, confirming the data of Nakano et al. who also showed that such lineage positive cell form single and multilineage erythroid and myeloid colonies in vitro, and erythrocytes expressing both primitive and definitive hemoglobins in vivo. In this study, the origin of these blood cells was attributed to the hemogenic endocardium; however our new lineage tracing data strongly suggest that they arise from hemogenic endothelium of the yolk sac, AGM region of the dorsal aorta, or liver. No such lineage^+^ cells were found in the adult in the Nakano study.

For the benefit of the reviewers, in a preliminary screen we also assessed whether Nkx2-5 lineage^+^ cells could be found in adult bone marrow and spleen. Results indicate that 1 in 20 mice screened showed significant contribution to both organs but zero contribution in the other 19 mice. Positive controls (germline deletion of the Cre reporter) showed the expected high contribution to bone marrow and spleen. We will not present this data in the revised manuscript because only a single positive mouse was found and because individual blood lineages and serial transplantation studies were not assessed. Nonetheless the results serve to suggest that extra-cardiac Nkx2-5 lineage^+^ cells can contribute to adult blood lineages, albeit rarely, so not in a physiologically significant way. We believe that the Nkx2-5 lineage+ cells contribute to hemopoiesis only in the early stages of development.

We would like to add that our work reveals, from a cardiac development perspective, a novel mesodermal progenitor population, which is not part of the FHF or SHF. We provide compelling evidence that this population of cardiovascular progenitors shares numerous characteristics with hemogenic angioblasts (including gene expression and enhancer expression patterns, migration pattern, differentiation in culture, and in vivo cluster localization in the DA and the heart). We feel that these findings in addition to the lineage tracing and expression data in mouse embryos are novel and important, and we believe are of significant importance to the cardiac, vascular and hemopoietic fields. Continuous time lapse videos for more than 24-30 hours is technically impossible given the current tools due to the development and turning of the chick embryo. Our current technique is limited to tracing cells up to St. 12. At later stages the chick embryo becomes opaque and the position of the heart changes dramatically.

To further address the question related to the actual dynamic expression of Nkx2.5 and its enhancer we have taken several additional approaches, as noted in our response to reviewer 1.

\[Editors\' note: the author responses to the re-review follow.\]

*Essential small, but important, revisions and minor points:*

*There are a number of recommendations concerning data presentation and edits that should be made before the final manuscript is accepted.*

*Reviewer \#1 (Minor comments):*

*1) [Figure 2](#fig2){ref-type="fig"}: The images are a little difficult to interpret. Higher magnification images would support the claim that the cells in the populations are mNkx2.5-en and mlsl1-en double positive or single positive. Also, labelling regions such as cardiac crescent, area vasculosa and heart tube etc. would enhance readability.*

The figure has been revised according to the reviewers' suggestions. Higher magnification panels were added to the figure and key anatomical structures are now marked.

*2) Introduction, second paragraph: some references are missing and it would be more precise to write: However, while blood cell formation from \"hemogenic endothelium\" has been visualised directly in multiple animal models (Boisset et al., 2010; Lam et al., 2010, Bertrand 2010, Kissa 2010), and* in vitro *during ES cells differentiation (Eilken et al., 2009; Lancrin 2009), the existence* in vivo *of a bipotential hemangioblast that contributes to both blood and endothelial cells remains controversial (Hirschi, 2012).*

We modified the sentence according to the suggestion. These relevant papers are now cited in the text. We thank the reviewer for this.

*3) I am not sure why the authors do not call their Nkx2.5 cell population a hemangioblast population as these cells in nascent mesoderm are able to form both endothelial and blood cells as stated in the abstract (although it is not shown at a clonal level). Also, the authors do not present enough data to claim that they uncovered a novel role of Nkx2.5 (Abstract and end of the Introduction), the data presented are mostly descriptive and establish mainly that Nkx2.5 is expressed in hemangioblast. The Abstract and text should be changed accordingly. I would propose for the Abstract \"Taken together, we identified a hemangioblast cell lineage characterized by transient Nkx2.5 expression that contributes to hemogenic endothelium and endocardium, uncovering Nkx2.5 as a novel marker of hemangioblast lineage specification and diversification.\"*

Basically, we agree with the reviewer that our study mainly deals with the expression of Nkx2.5 in hemangioblasts. More mechanistic data such as the knockout of Nkx2.5 in endothelial/blood lineages would be important for future studies. The severe defects in early yolk sac vasculature observed in the Nkx2.5 null embryos coupled to our gain of function experiments in the chick, as well as other recent studies support the idea that Nkx2.5 is more than "just a marker" for hemangioblasts. We have modified the Abstract along the reviewer suggestion: "we identified a hemogenic angioblast cell lineage characterized by transient Nkx2.5 expression that contributes to hemogenic endothelium and endocardium, suggesting a novel role for Nkx2.5 in hemoangiogenic lineage specification and diversification". We have retained reference to Nkx2.5 expression in the "hemoangiogenic lineage", avoiding specific reference to hemangioblasts, as this historical term infers a bipotential progenitor, the presence of which in vivo remains controversial, as discussed (Nishikawa, 2012).

*4) When the authors discuss in the second paragraph of the Introduction and in the fifth and eighth paragraphs of the Discussion, the migration of hemogenic endothelium precursors to different embryonic sites of hematopoiesis (Tanaka 2014), they should also mention the recent paper by Eliades 2016 (PMID:27239041). Also, it would be interesting to mention the potential role of RUNX1 in cell migration/adhesion (PMID:25082880). Finally, the meaning of the last sentence of this paragraph is not clear: Runx1 is essential at this early stage for priming the establishment of hemogenic endothelial cell fate in the aorta-gonad-mesonephros (AGM) region, where Runx1 is also activated, and for definitive hemopoiesis (Tanaka et al., 2012).*

We now discuss these references and simplified the above sentence.

*5) Please rename the video titles so that they fit the video titles in the manuscript text.*

The video titles now match the titles in the manuscript.

*6) [Figure 4H](#fig4){ref-type="fig"}. Can the authors supply single channel images to support the claim of Hb-en and mNkx2.5-en double positive cells in the endocardium?*

[Figure 4](#fig4){ref-type="fig"} was updated with the requested images. [Figure 4](#fig4){ref-type="fig"} now includes panels 4H'-H''' with high magnifications of single channels for each enhancer.

*7) [Figure 5D](#fig5){ref-type="fig"}. Only a single RUNX1+/Nkx2.5 en+ cell is shown. What percentage of RUNX1+ HE cells found at this stage in the dorsal aorta are Nkx2.5en+?*

Due to the transient and mosaic nature of the electroporation method in the chick it is more difficult to detect *mNkx2.5*-en^+^ (GFP^+^) cells in the dorsal aorta in comparison to genetic labeling in mice. This may lead to an underestimation of GFP^+^ cells as the embryo develops. Still, we counted GFP^+^ cells in the dorsal aorta and found that \~15% of Runx1^+^ cells in this site are GFP^+^ (Runx1^+^/*mNkx2.5*-en^+^). Strikingly, this number is in line with the mouse lineage tracing data of *Nkx2.5*-derived angioblasts expressing Runx1 (\~15-16%, [Figure 9---figure supplement 1I](#fig9s1){ref-type="fig"}). We discuss this point in the text of [Figure 9](#fig9){ref-type="fig"} (subsection "Mouse Nkx2-5 lineage^+^ cells contribute to the hemogenic endothelium of the dorsal aorta".

*8) [Figure 7D](#fig7){ref-type="fig"}: Mouse Nkx2.5 lineage+ cells contribute to yolk sac vasculature. Pecam1 staining is required to confirm the endothelial nature of the Nkx2.5 lineage+ cells associated with the yolk sac vasculature.*

We were unable to detect Pecam1 staining in yolk sac vessels at E9.0 and suspect that these immature vessels do not express high levels of this mature endothelial cell marker. In order to confirm that Nkx2-5^+^ lineage traced cells contribute to the endothelium of the yolk sac vasculature, co-immunostaining was performed at E9.0 with the endothelial markers Vegfr2/Flk1 and VE-cadherin, detecting the Nkx2-5 lineage^+^ cells using two different Cre reporter lines *R26R^YFP^*and *Z/EG*. The majority of Nkx2-5-lineage traced YFP/GFP-positive cells lining the yolk sac vessels co-stained with Vegfr2 and VE-cadherin, suggesting contribution to the endothelium of these vessels (see new textin subsection "Mouse Nkx2-5 lineage^+^ cells contribute to yolk sac vasculature", first paragraph and [Figure 9---figure supplement 2](#fig9s2){ref-type="fig"}).

*9) Do the Nkx2.5 expressing cells detected in E7.5 murine nascent mesoderm (*Figure 7---figure supplement 2*) also express hematopoietic or endothelial markers?*

To address this question, we have exploited the extensive single cell transciptome data of Berthold Gottgens and colleagues (Scialdone et al., 2016). In this work, they profiled the transcriptome of single cells from E6.5 epiblast, as well as Flk1^+^ mesodermal cells from E7.0-E7.75 embryos. Epiblast cells, extraembryonic ectoderm and some 7 different mesodermal cell types were identified using the cell surface markers Flk1 and CD41, as well as the transcriptome data. We interrogated the single cell data in E7.0-E7.75 embryos for *Nkx2-5* expression. While expression was not detected in epiblast or extra-embryonic ectodermal cells, expression was evident in \~7% of nascent mesodermal cells and \~30% of posterior mesoderm and pharyngeal mesoderm. Notably, \~30% of vascular endothelial cells and allantois (one extraembryonic site of hemopoiesis), and \~10% of early blood progenitor were also positive. Thus, as suggested by immunofluorescence, *Nkx2-5* is expressed in endothelial cells and blood progenitors in early murine embryos. This data is discussed in the last paragraph of the subsection "Mouse Nkx2-5 lineage^+^ cells contribute to yolk sac vasculature" and shown in [Figure 9---figure supplement 3](#fig9s3){ref-type="fig"}.

*10) [Figure 8B](#fig8){ref-type="fig"} the expression of RUNX1 and Tal1 is not obvious.*

In the text we now note that the expression of these genes is very low.

*11) Discussion, first paragraph: are the authors claiming the presence of hemogenic endothelium in the liver? This is not supported by any data.*

Our data in mice reveal that a proportion of cells expressing HSC markers Runx1^+^ and CD41^+^ in the fetal liver are derived from the Nkx2.5^+^ lineage ([Figure 9K-L'''](#fig9){ref-type="fig"}). Significant numbers of co-labeled cells were observed in the liver at E10.5. Characterization of these liver progenitors would require further studies. The text was revised to make this point clear.

*12) Subsection "Mouse Nkx2-5 lineage^+^ cells contribute to yolk sac vasculature", last paragraph: Typo misspelling of \'lineage\'*

Fixed.

*13) Subsection "Nkx2.5 is expressed in the nascent mesoderm in the primitive streak of chick embryos", second paragraph: Typo misspelling of \"immunofluorescence\"*

Fixed.

*14) Subsection "Ectopic expression of Nkx2.5 induces hemangioblast gene expression", last paragraph: Typo misspelling of \'definitive\'*

Fixed and many thanks for these corrections.

*Reviewer 2 (Minor comments):*

*1) The authors should start the paper with the mouse data, which they then confirm using expression of the mouse enhancer in chick embryos. This would make the paper somewhat easier to read, as in the current version they switch from chick to mouse then back to chick.*

We thank the reviewer for this suggestion but we feel that the story flows nicely as is starting with the chick data that identified a population of hemangioblasts labeled by the *Nkx2.5* enhancer. We then go on to confirm the data in mice using *Nkx2-5*-LacZ expression and lineage tracing methods. We rearranged the figures such that all the chick data now precede the mouse data to avoid the back and forth situation between the two models.

*2) Question regarding the mouse data: [Figure 7I and J](#fig7){ref-type="fig"} show that the majority of YFP cells in the DA are also Runx1+. However, this is not reflected in the quantification in [Figure 7---figure supplement 1I](#fig7s1){ref-type="fig"}. Please clarify.*

Please note that formerly [Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1I](#fig7s1){ref-type="fig"} are now [Figure 9](#fig9){ref-type="fig"} and [Figure 9---figure supplement 1I](#fig9s1){ref-type="fig"}, respectfully.

We understood that reviewer's comments to mean that in [Figure 9 I-J](#fig9){ref-type="fig"}''', few Runx1- YFP^+^ cells are present in the sections shown, whereas in [Figure 9---figure supplement 1I](#fig9s1){ref-type="fig"}, some 23% of endothelial cells were scored as Runx1^-^ YFP^+^. It is true that few such endothelial cells were present in the sections selected for [Figure 9I-J](#fig9){ref-type="fig"}''', and we have now added a new set of panels to [Figure 9---figure supplement 1J-J](#fig9s1){ref-type="fig"}''' to show a region in which there are more Runx1^-^ YFP^+^ cells (highlighted by green arrows), and referenced this in the first paragraph of the subsection "Mouse Nkx2-5 lineage^+^ cells contribute to the hemogenic endothelium of the dorsal aorta".

Please note that the quantification data shown in [Figure 9---figure supplement 1I](#fig9s1){ref-type="fig"} are robust -- fifteen 10 μm sections were analyzed from three different *Nkx2-5^irescre^; R26R^YFP^* embryos. A total of 859 cells were scored.

*3) Current [Figure 1](#fig1){ref-type="fig"} starts off with an Isl1 enhancer, which is really used as a negative control. The data should be reorganized to start off with the Nkx2.5 enhancer that they use to drive GFP expression in chick embryos. Panel J reads Isl1-en I suppose this should read Nkx2.5-en. There are several J\' panels. Overall, figure legends should be matched to Figures ([Figure 6](#fig6){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} are other examples!).*

We thank the reviewer for his suggestion and we modified [Figure 1](#fig1){ref-type="fig"} accordingly. The change is also reflected in the text. Corrections to figure legends and within the figures were also made. Thanks again!

*4) Do the authors claim that the mouse enhancer is sufficient to drive Nkx2.5 expression in hemogenic endothelium and endocardium? Please comment.*

We argue that the mouse enhancer that we used in the chick embryos is sufficient to drive the reporter expression in a special population of hemogenic angioblasts that could be found in the hemogenic endothelium and endocardium. We could show that this occurs due to a transient expression of Nkx2.5 at RNA and protein expression in the nascent mesoderm during gastrulation. The mouse data support this conclusion, although the onset of expression in mouse occurs later. We could not show Nkx2.5 protein expression in hemogenic endothelium as levels are presumably downregulated by the time that angioblast cells adopt hemogenic characteristics, likely by a mutual inhibition of hemogenic transcription factors (e.g., Scl1/Tal1).

*5) Data in [Figure 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"} use electroporation with a GFP-tagged Cerberus hemangioblast enhancer Hb-en as a positive control. I find co-localization of Hb-en and Nkx2.5-en in [Figure 3](#fig3){ref-type="fig"} convincing, but data in [Figure 4](#fig4){ref-type="fig"} should track double-labeled Hb-en and Nkx2.5-en cells, or at least single labeled Nkx2.5+ cells! Likewise, explant data in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} should use both Nkx2.5-en and Hb-en.*

Following the reviewer's request we performed additional experiments to address the above issues. We have added new data of a time-lapse analysis performed on *mNxk2.5* and *Hb* enhancers expressing embryo ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [Video 4](#media4){ref-type="other"}). In this experiment we could track double positive cells (*mNkx2.5*-en^+^/*Hb*-en^+^) that migrate into heart tube from St.7 to St. 11. In addition we detected numerous double positive cells that contribute to the extraembryonic vasculature in line with the mouse lineage tracing data.

In addition, we performed a new LPM explant assay of embryos electroporated with the *mNkx2.5*-en plasmid. We now show that a subpopulation of *mNkx2.5*-en^+^ cells in the LPM has a hemogenic potential highlighted by their Runx1 expression ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

*6) Do Nkx2.5+ cells contribute some or all of the hemogenic endothelial cells in the DA and endocardium? And when and how do they get to that location? Please discuss.*

As stated above and based on both model systems, about 15% of the Nkx2.5 expressing cells in the LPM/extraembryonic mesoderm adopt a hemogenic angioblast characteristic, as judged by marker expression. Our methodologies could not adequately address whether all hemogenic endothelium in the DA and endocardium originate from Nkx2.5 expressing (or lineage derived) cells. Conceivably, hemogenic endothelial cells have multiple origins but this would require further studies. We added a sentence regarding this aspect in the Discussion.

[^1]: These authors contributed equally to this work.
